Home
  >  
Section 36

EurekaMag Full Text Articles Chapter 35,509



References:

Mizushima, A.; Kawauchi, Y.; Katashima, S.; Kamiyama, Y.; Kugimiya, T. 2003: Plasma Glutathione S-Tarnsferase Concentrations and Indocyanine Green Clearance as Measures of Hepatocellular Integrity in Patients Undergoing Laparoscopic Surgery with Propofol Anesthesia. Anesthesiology Abstracts of Scientific Papers Annual Meeting: Abstract No. A-801
Huh, Y.R.; Hwang, K.H.; Lim, H.S. 1999: Plasma HDL-cell level associates negatively with plasma triglyceride and insulin level in hypercholesterolemic patients. FASEB Journal 13(4 Part 1): A559
Sun, J.Z.; Ding, I.; Barrett, J.A.; Phang, S.E.; Fu, D.D.; Liu, W.M.; Constine, L.S.; Wang, X.; Okunieff, P. 1999: Plasma HGF, EGF, PDGF-AB and TGF-beta1 in leukemia patients undergoing bone marrow transplantation. Proceedings of the American Association for Cancer Research 40: 720-721
Dirkx, T.; Speth, R.; Mcpherson, E.; Luo, Z.; Saunders, K.; Bagby, S. 2004: Plasma IGF-1 in Fetal, Neonatal, and Adult Microswine Offspring of Maternal Protein Restriction. FASEB Journal 18(4-5): Abstract 451
Vestergaard, M.; Jorgensen, K.F.; Andersen, H.R.; Bligaard, H.B.; Sejrsen, K. 2002: Plasma IGF-I does not reflect growth rate and fattening in finishing-fed dry dairy cows. Journal of Dairy Science 85(Suppl 1): 194-195
Chavatte Palmer, P.; Heyman, Y.; Monget, P.; Richard, C.; Kahn, G.; Le Bourhis, D.; Vignon, X.; Renard, J.P. 2000: Plasma IGF-I, IGFBP and GH concentrations in cloned neonatal calves from somatic and embryonic cells Preliminary findings. Theriogenology 53(1): 213
Taylor, V.J.; Beever, D.E.; Wathes, D.C. 2000: Plasma IGF-I, energy balance status and ovarian function in dairy cows producing average and high milk yields in the early post partum period. Journal of Reproduction and Fertility Abstract Series 26: 34-35
Takai, A.; Hori, T.; Yagi, S.; Oka, K.; Kanemitsu, Y.; Sudo, N.; Shioda, S.; Arimura, A. 1999: Plasma IL-6 and its pyrogenicity during noninflammatory stress. Yamashita, H, Funder, J W, Verbalis, J G, Ueta, Y, Endo, Y International Congress Series; Control mechanisms of stress and emotion: Neuroendocrine-based studies 173-177
Brockow, K.; Akin, C.; Huber, M.M.; Metcalfe, D.D. 2002: Plasma IL-6 correlates with disease category and with hematological parameters in patients with mastocytosis. Journal of Allergy and Clinical Immunology 109(1 Suppl): S158
Balakrishnan, V.S.; Guo, D.; Perianayagam, M.C.; Jaber, B.L.; Pereira, B.J.; Rao, M.; Hemo Study Group 2003: Plasma IL-6 predicts clinical outcomes in prevalent hemodialysis patients. Journal of the American Society of Nephrology 14(Abstracts Issue): 3A
Quigley, J.D.; Kost, C.A.; Anspach, T.M. 2001: Plasma IgG concentration in neonatal calves in response to a colostrum supplement or colostrum replacer and addition of deoxycholic acid. Journal of Dairy Science 84(Suppl 1): 224
Dewey, K.G.; Nommsen Rivers, L.; Lonnerdal, B. 2004: Plasma Insulin and Insulin-Releasing Amino Acid Concentrations are Higher in Formula-fed than in Breastfed Infants at 5 mo of age. FASEB Journal 18(4-5): Abstract 564
He, Y.; Mattern, J.R.; Pyter, L.M.; Fadem, B.H.; Harder, J.D. 2002: Plasma LH concentrations in male and female opossums following gonadectomy and exogenous GnRH. Hormones and Behavior 41(4): 470
Panuccio, V.; Mallamaci, F.; Tripepi, G.; Zoccali, C. 2002: Plasma Leptin and bone turnover in hemodialysis patients. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 198
Patton, William Nigel; Hock, Barry D.; Mckenzie, Judy L.; Haring, Lisa F.; Estey, Elihu H.; Albitar, Maher; Et Al 2002: Plasma Levels of Soluble CD86 Are an Independent Prognostic Marker in AML but Not MDS. Blood 100(11): Abstract No. 2970
Aleil, B.; Mossard, J.M.; Wiesel, M.L.; Wolff, V.; Attali, P.; Gachet, C.; Lanza, F.; Cazenave, J.P. 2002: Plasma Levels of Soluble Platelet Glycoprotein V in Acute Coronary Syndromes A Tool To Monitor Platelet Activation by Thrombin in Arterial Thrombosis. Blood 100(11): Abstract No. 3938
Borzecki, A.; Bojarska Junak, A.; Rolinski, J.; Borzecka, H.; Kaluzny, Z.; Dmoszynska, A. 2002: Plasma Levels of Tumor Necrosis Factor-alpha in Patients With B-Cell Chronic Lymphocytic Leukemia. Blood 100(11): Abstract No. 4967
Zhu Jianlin; Xiong Xiaozhong; Zhao Shuiping; Wang Zhonglin; Lou Lin; Hang Quanyue 1999: Plasma Lp levels and correlation of Lp with fibrinolysis activation in chronic renal failure. Hunan Yike Daxue Xuebao 24(4): 366-368
Tsimikas, S.; Bergmark, C.; Binder, C.; Horkko, S.; Miller, E.; Juliano, J.; Hobbs, H.; Witztum, J.L. 2001: Plasma Lp levels strongly correlate with circulating oxidized phospholipids on ApoB Implications for atherogenesis. Circulation 104(17): 2; 65
Cinaz, P.; Bideci, A.; Tumer, L.; Ozkaya, O.; Sayan, H. 1999: Plasma MDA concentrations in children with IDDM. Hormone Research 51(Suppl 2): 93
Molloy, K.J.; Loftus, I.M.; Evans, J.; Bell, P.R.F.; Naylor, A.R.; Thompson, M.M. 2003: Plasma MMP-9 A marker of cerebral damage. European Heart Journal 24(Abstract Suppl): 419
Squire, I.B.; Ng, L.L.; Loftus, I.; Evans, J.; Thompson, M. 2002: Plasma MMP-9 correlates with N-terminal ProBNP and predicts ventricular function following acute MI. Circulation 106(19): II528
Kay, N.E.; Bone, N.D.; Pittner, B.T.; Jelinek, D.F.; Leland, P.; Frank, D.A.; Battle, T.E.; Puri, R.K. 2002: Plasma Membrance IL-4 Receptors Can Be Targeted To Eliminate B-Chronic Lymphocytic Leukemia B Cells. Blood 100(11): Abstract No. 2324
Szulc, M.; Kostrubiec, M.; Bochowicz, A.; Kuch Wocial, A.; Kurzyna, M.; Fijalkowska, A.; Torbicki, A.; Pruszczyk, P. 2003: Plasma N terminal pro-brain natriuretic peptide reflects the severity of right-ventricular overload in patients with acute pulmonary embolism. European Heart Journal 24(Abstract Suppl): 138
Allen, J.; Gow, A.; Cobb, F. 2003: Plasma N-oxides discriminate clinical health status following exercise testing and reflect regional endothelial function. Free Radical Biology and Medicine 35(Suppl 1): S80
D.W.nter, R.J.; Stroobants, A.; Koch, K.T.; Bax, M.; Schotborgh, C.E.; Mulder, K.; Fischer, J.; Van Straalen, J.P.; Tijssen, J.G.; Piek, J.J.; Sanders, G.T. 2003: Plasma N-terminal pro-B-type natriuretic peptide is associated with death or non-fatal myocardial infarction following percutaneous coronary intervention. Circulation 108(17): IV538
Hartmann, F.S.; Richardt, G.; Packer, M.; Coats, A.J.; Fowler, M.B.; Krum, H.; Mohacsi, P.; Rouleau, J.L.; Tendera, M.; Castaigne, A.; Baumann, M.; Trawinski, J.; Horsch, S.; Amann Zalan, I.; Ka 2002: Plasma N-terminal pro-BNP predicts the occurrence of major clinical events in severe chronic heart failure Results of a substudy of the COPERNICUS trial. Journal of the American College of Cardiology 39(5 Suppl A): 200A
Hobbs, F.D.R.; Davis, R.C.; Roalfe, A.K.; Kenkre, J.E.; Hare, R.; Trawinski, J.; Davies, M.K. 2000: Plasma N-terminal pro-brain natriuretic peptide has similar predictive value to brain natriuretic peptide in diagnosis of heart failure in the community. European Heart Journal 21(Abstract Suppl): 133
Luchner, A.; Hengstenberg, C.; Lowel, H.; Trawinski, J.; Baumann, M.; Holmer, S.; Riegger, G.A.; Schunkert, H. 2001: Plasma N-terminal pro-brain natriuretic peptide in patients after myocardial infarction A biochemical marker of cardio-renal function. European Heart Journal 22(Abstract Suppl): 304
Omland, Torbjorn; Hall, Christian; De Lemos, James A. 2001: Plasma N-terminal pro-brain natriuretic peptide is an independent prognostic indicator in patients with non-ST-segment elevation acute coronary syndromes A TIMI 11b Substudy. Circulation 104(17): 2; 698
Talwar, S.; Downie, P.F.; Squire, I.B.; Davies, J.E.; Barnett, D.B.; Ng, L.L. 1999: Plasma N-terminal proBNP and cardiotrophin-1 in aortic stenosis. European Heart Journal 20(ABSTR Suppl ): 557
Ishibashi, T.; Matsubara, T.; Yamazoe; Hori, T.; Ida, T.; Aizawa, M.Y.; Yoshida, J.; Nishio, M. 1999: Plasma NOx balance across coronary circulation in patients with coronary organic stenosis and with vasospastic angina. Acta Physiologica Scandinavica 167(Suppl 645): 50
Overgaard, J.; Nordsmark, M.; Alsner, J.; Eriksen, J.G.; Horsman, M.R. 2003: Plasma Osteopontin predicts hypoxia and response to the hypoxic sensitiser Nimorazole in radiotherapy of head and neck cancer Results from the randomized DAHANCA 5 Trial. EJC Suppls 1(5): S144
Caini, P.; Guerra, C.T.; Giannelli, F.; Buzzelli, G.; Gragnani, L.; Laffi, G.; Gentilini, P.; Zignego, A.L. 2002: Plasma PAF-AH biological activity decreases in patients with HCV chronic infection. Hepatology 36(4 Part 2): 272A
Hamer, P.J.; Goshgarian, N.; Smith, J.; Trivedi, D.; Tighe, W.; Lipton, A.; Ali, S.M.; Leitzel, K.; Demers, L.; Harvey, H.A.; Carney, W.P. 2003: Plasma PAI-1 and uPAPAI-1 complex levels as predictive and prognostic factors in patients with metastatic breast cancer. Proceedings of the American Association for Cancer Research 44: 1270-1271
Yoo, J.S.; Seo, J.B.; Oh, J.W.; Song, S.H.; Kim, M.H.; Huh, W. 1999: Plasma PAI-1 antigen concentration in non-insulin dependent diabetic patients Implication for diabetic retinopathy. IOVS Investigative Ophthalmology and Visual Science 40(4): S310
Mlynarska, A.; Waszyrowski, T.; Kasprzak, J.D. 2003: Plasma PAI-1 antigen concentration predicts clinical outcome of thrombolytic treatment of acute myocardial infarction. Journal of the American College of Cardiology 41(6 Suppl A): 232A
Strauss, B.H.; Lau, H.K.; Bowman, K.A.; Sparkes, J.; Chisholm, R.J.; Teitel, J.M. 1999: Plasma PAI-1 antigen levels predict coronary restenosis. Circulation 100(18): 1; 449
Ominato, M.; Shirai, S.; Nabana, N.; Toyama, K.; Ishii, Y.; Satoh, T.; Owada, S.; Shimazu, T.; Suzuki, N.; Jyuni, M. 2001: Plasma PBN radical spin adduct is a nobel oxidative stress marker in renal failure patients. Nephrology Dialysis Transplantation 16(6): A138
Barcia, C.; Bautista, V.; Sanchez Bahillo, A.; Almirall, H.; De La Calzada, M.D.; Sagales, T.; Obeso, J.A.; Herrero, M.T. 1999: Plasma Prolactin and Cortisol concentrations in chronic parkinsonian monkeys Changes in circadian rhythms. Society for Neuroscience Abstracts 25(1-2): 329
Durie, B.G.M.; Urnovitz, H.B. 2003: Plasma RNA in active myeloma codes for IL-4 and includes an Alu sequence involved in the Dkk-1/Wnt-10b/PPAR molecular pathway. Blood 102(11): 378b-379b
Torres Rodriguez, L.; Brito Orta, D.; Cruz Rivera, C.; Rodriguez Martinez, M. 2004: Plasma Renin Activity in Chronic Sino-Aortic Denervated Rats under Low and High Sodium Diet. FASEB Journal 18(4-5): Abstract 474
Ottesen, L.H.; Harry, D.; Moore, K. 2000: Plasma S-nitrosothiols increase in biliary cirrhosis and endotoxemia. Journal of Hepatology 32(Suppl 2): 42
Flowers, C.H.; Cook, J.D. 1999: Plasma Spotted onto filter paper for the assessment of iron status. FASEB Journal 13(4 Part 1): A265
Ye, H.; Gu, L.J.; Xue, H.L.; Tang, J.Y.; Zhao, H.J.; Pan, C.; Chen, J.; Liang, A.B.; Jiang, H.; Bian, J.G.; Wang, Y.P. 2002: Plasma Steady-State Concentration of High-Dose Methotrexate Measured in Chinese Children with Acute Lymphoblastic Leukemia. Blood 100(11): Abstract No. 4580
Neill, E.K.T.; Stewart, R.J.; Schneider, M.M.; Taylor, F.B.J.; Nesheim, M.E. 2003: Plasma TAFIa levels and antifibrinolytic potential measured in a baboon sepsis model. Blood 102(11): 791a-792a
Coupes, B.M.; Williams, S.; Roberts, I.S.D.; Short, C.D.; Johnson, R.W.G.; Brenchley, P.E.C. 2000: Plasma TGFbeta1 expression during a randomised study of therapy with cyclosporin A and sirolimus versus sirolimus in renal allograft recipients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 684A-685A
Iwasaki, Y.; Ichikawa, Y.; Igarashi, O.; Aoyagi, J.; Konno, S.; Iguchi, H.; Fujioka, T.; Kawabe, K. 2003: Plasma TGFbeta1 in ALS patients. Acta Neurologica Scandinavica 108(3): 221
Holten Andersen, M.; Nielsen, H.J.; Christensen, I.J.; Brunner, N. 2002: Plasma TIMP-1 as a diagnostic and prognostic marker in patients with colorectal cancer. Anticancer Research 22(6C): 4316
Caorsi, C.; Quintana, E.; Valdes, S.; Munoz, C. 2000: Plasma TNF-alpha and hemodynamic changes during sepsis like-state. Journal of Endotoxin Research 6(2): 114
Ko, K.S.; Torres, C.L.; Fascetti, A.J.; Stipanuk, M.H.; Rogers, Q.R. 2004: Plasma Taurine Does Not Decrease in Copper-Deficient Rats. FASEB Journal 18(4-5): Abstract 373
Khan, M.M.; Hattori, T.; Niewiarowski, S.; Edmunds, L.H.nry Jr; Colman, R.W. 2002: Plasma Tissue Factor in Combination with Mononuclear Cells Accelerates Activation of Factor VII in Cardiac Surgical Wounds. Blood 100(11): Abstract No. 1895
Aksoy, M.; Gursurer, M.; Emre, A.; Eren, M.; Siber, T.; Unal, D.; Ersek, B. 1999: Plasma Troponin T level in patients with unstable angina pectoris Association with myocardial perfusion and functional abnormalities on gated SPECT imaging and angiographic morphology. Journal of the American College of Cardiology 33(2 Suppl A): 345A
Lim, H.S.; Blann, A.D.; Lip, G.Y.H. 2004: Plasma VEGF and angiopoietin-2 are elevated in diabetes but may not mediate the effects of hyperglycaemia on atherosclerosis. Clinical Science (London) 106(Suppl 50): 6P-7P
Freedman, B.; Vale, P.R.; Kalka, C.; Losordo, D.W.; Kearney, M.; Symes, J.F. 2000: Plasma VEGF levels after intramyocardial and intramuscular VEGF gene transfer in patients with coronary artery and peripheral artery disease. Circulation 102(18): 2; 10
Guadagni, E.; Spila, A.; D'alessandro, R.; Aloe, S.; Ettorre, G.M.; Vennarecci, G.; Lonardo, M.T.; Giovannelli, L.; Bellis, L.; Puoti, C.; Visco, G.; Santoro, E. 2004: Plasma VEGF levels correlate with haemostatic activation in HCC patients. Journal of Hepatology 40(Suppl 1): 78
Gavin, T.P.; Kraus, R.M.; Stallings, H.W.I.i; Yeager, R.C. 2003: Plasma VEGF protein response to acute exercise in sedentary and endurance trained humans. Medicine and Science in Sports and Exercise 35(5 Suppl): S42
Preston, A.M.; Gomez, L.E.; Rodriguez, C.A. 2001: Plasma Vitamin C and food choices in Puerto Rican children Effect of gender, age and smoke exposure. FASEB Journal 15(4): A262
Pedersen, P.K.; Sj, J.L.G.; Juel, C. 2001: Plasma acid-base status and hyperventilation during cycling at MaxLaSS in low and high lactate responders. Medicine and Science in Sports and Exercise 33(5 Suppl): S314
Borawski, J.; Naumnik, B.; Myśliwiec, M.ł 2004: Plasma activin a in hemodialysis patients: does brand of immunoassay matter?. Kidney International 66(1): 465
Slingerland, R.J.; Ruiter, J.P.N.; De Visser, M.; Spaapen, L.J.M.; Skladal, D.; Sass, J.O.; Wanders, R.J.A.; Duran, M. 2003: Plasma acylcarnitines and CPT-2 deficiency. Journal of Inherited Metabolic Disease 26(Suppl 2): 88
Sud, K.; Khullar, M.; Sharma, M.C.; Kohli, H.S.; Jha, V.; Gupta, K.L.; Sakhuja, V. 2002: Plasma adenosine levels do not modulate blood pressures during hemodialysis. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 128
Stenvinkel, P.; Marchlewska, A.; Pecoits Filho, R.; Heimburger, O.; Hoff, C.; Holmes, C.; Axelsson, J.; Barany, P.; Lindholm, B.; Nordfors, L. 2003: Plasma adiponectin and its relations to albuminuria, type of diabetes, body composition, inflammation and genetic variations in the gene encoding adiponectin in ESRD. Journal of the American Society of Nephrology 14(Abstracts Issue): 531A
Wiecek, A.; Chudek, J.; Funahashi, T.; Karkoszka, H.; Ignacy, W.; Adamczak, M.; Kokot, F. 2002: Plasma adiponectin concentration before and in the early period after kidney transplantation. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 737A
Adamczak, M.; Wiecek, A.; Funahashi, T.; Chudek, J.; Kokot, F.; Matsuzawa, Y. 2002: Plasma adiponectin concentration in patients with essential hypertension. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 36
Hiramatsu, S.; Tajiri, Y.; Karashima, T. 2002: Plasma adiponectin concentration is a reliable indicator for insulin sensitivity and increased by treatment with thiazolidinedione. Diabetologia 45(Suppl 2): A 225
Gao, J.; Islam, A.; Deacon, R. 2003: Plasma adiponectin concentrations and whole-body insulin sensitivity and responsiveness in obese zucker rats treated with pioglitazone. Diabetes 52(Suppl 1): A287
Tsigos, C.; Kyrou, I.; Tsiotra, P.; Tentolouris, N.; Raptis, S.A.; Katsilambros, N. 2003: Plasma adiponectin correlates inversely with plasma TNFalpha and insulin resistance in obese women. International Journal of Obesity 27(Suppl 1): S94
Iacobellis, G.; Zappaterreno, A.; Tiberti, C.; Ribaudo, M.; Iannucci, C.; Leonetti, F.; Di Mario, U. 2003: Plasma adiponectin is related to epicardial adipose tissue in uncomplicated obesity. Diabetes and Metabolism 29(Hors serie 2): 4S128
Sierksma, A.; Funahashi, T.; Matsuzawa, Y.; Hendriks, H.F.J. 2002: Plasma adiponectin levels and insulin sensitivity with moderate alcohol consumption. Alcoholism Clinical and Experimental Research 26(5 Suppl): 150A
Vendramini, M.; Ferreira, S.; Gimeno, S.; Kasamatsu, T.; Miranda, W.; Moises, R. 2003: Plasma adiponectin levels and the development of type 2 diabetes in Japanese-Brazilians. Diabetes 52(Suppl 1): A333
Fukuda, I.; Hizuka, N.; Ishikawa, Y.; Itoh, E.; Yasumoto, K.; Murakami, Y.; Sata, A.; Tsukada, J.; Kurimoto, M.; Okubo, Y.; Takano, K. 2004: Plasma adiponectin levels in adult growth hormone deficiency and acromegaly. Growth Hormone and IGF Research 14(2): 141
Shen M.H.; Chu N.F.; Wu D.M. 2003: Plasma adiponectin levels in relation to atherosclerotic lipid profiles among school children in Taiwan. International Journal of Obesity 27(Suppl 1): S65
Cseh, K.; Baranyi, E.; Melczer, Z.; Speer, G.; Kovacs, M.; Kaszas, E.; Hajos, P.; Winkler, G. 2003: Plasma adiponectin, cytokines and insulin resistance in healthy pregnant women and patients with gestational diabetes. Diabetologia 46(Suppl 2): A 249
Perkins, G.; Lamb, S.; Erb, H.N.; Schanabacher, B.; Nydam, D.; Divers, T.J. 2001: Plasma adrenocorticotropin concentrations and clinical response in horses treated for equine Cushings disease with cyproheptadine or pergolide. Journal of Veterinary Internal Medicine 15(3): 286
Nakamura, S.; Isaji, M.; Ishimori, M. 2004: Plasma adrenomedullin concentration patients with Graves' disease. Internal Medicine 43(7): 628-629
Nanke, Y.ki; Kotake, Shigeru; Akama, Hideto; Hara, Masako; Kamatani, Naoyuki 1999: Plasma adrenomedullin in patients with systemic sclerosis complicated with pulmonary hypertension. Arthritis and Rheumatism 42(9 Suppl): S207
Yudoh, K.; Matsuno, H.; Kimura, T. 1999: Plasma adrenomedullin in rheumatoid arthritis compared with other rheumatic diseases. Arthritis and Rheumatism 42(6): 1297-1298
Cecchin, E.; De Marchi, S.; Ciani, R.; Curcio, F.; Adorati, M.; Sepiacci, G.; Zanello, F.; Sechi, L.; Bartoli, E. 1999: Plasma adrenomedullin level in hemodialysis patients Relationship with left ventricular dilatation and systolic dysfunction. Nephrology Dialysis Transplantation 14(9): A218
Drueke, T.B.; Guerin, A.; Witko Sarsat, V.; Massy, Z.A.; Descamps Latscha, B.; London, G. 2001: Plasma advanced glycation end products and carotid intima/media thickness in hemodialysis patients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 200A
Brown, Clinton; Zhao, Zong H.; Alam, Anis L.; Thomas, Lorraine; Vasan, Sara; De Groof, Robert; Friedman, Eli A. 2003: Plasma advanced glycation end products level correlates closely with RBC deformability in patients with renal disease. Journal of the American Society of Nephrology 14(Abstracts Issue): 609A
Drueke, T.B.; Guerin, A.; Witko Sarsat, V.; Gausson, V.; Descamps Latscha, B.; London, G. 2000: Plasma advanced oxidation protein products are related to carotid intima/media thickness in hemodialysis patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 264A
Endemann, D.H.; Wolf, K.; Kurtz, A.; Riegger, G.A.J.; Kramer, B.K. 2002: Plasma aldosterone and adrenal aldosterone synthase are increased in a model of chronic renal failure despite a marked decrease of plasma renin activity Possible role of adrenal renin-angiotensin system. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 343A-344A
Mancini, T.; Kola, B.; Sardu, C.; Masini, A. 2000: Plasma aldosterone and cortisol response to low ACTH dose in normal subjects and in adrenocortical masses. Journal of Endocrinological Investigation 23(6 Suppl): 53
Yamada, T.; Shimonagata, T.; Ogita, H.; Hirata, A.; Fukunami, M. 1999: Plasma aldosterone level is an independent predictor of poor prognosis in patients receiving spironolactone with mild to moderate congestive heart failure. Circulation 100(18): 1; 784
Jorde, U.P.; Suryadevara, V.; Hammer, A.; Barbulescu, V.; Piscitelli, J.; Sonnenblick, E.H.; Lejemtel, T.H. 1999: Plasma aldosterone levels do not predict degree of angiotensin-converting-enzyme inhibition in heart failure patients. Journal of the American College of Cardiology 33(2 Suppl A): 214A
Aubertin-Leheudre, M.èn.; Koskela, A.; Samaletdin, A.; Adlercreutz, H. 2010: Plasma alkylresorcinol metabolites as potential biomarkers of whole-grain wheat and rye cereal fibre intakes in women. British Journal of Nutrition 103(3): 339-343
Chung, W.Y.; Tomlinson, B.; Benzie, I.F.F. 1999: Plasma allantoin Potential clinical application as an index of oxidative stress. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S325
Pathak, H.; Pavitt, D.; De Fonseka, S.; Alaghbandzadeh, J.; Bowler, J.; Reaveley, D.A. 2000: Plasma allantoin concentrations in stroke patients. Clinical Science 98(2): 17P
Reddi, A.S.; Baskin, S.; Wassel, E.; DeAngelis, B.; Baker, H. 1999: Plasma alpha-lipoic acid and total glutathione levels in patients on maintenance hemodialysis. Nephron 82(4): 357
Tamai, H.; Kim, H.S.; Hozumi, M.; Kuno, T.; Murata, T.; Morinobu, T. 2000: Plasma alpha-tocopherol level in diabetes mellitus. Biofactors 11(1-2): 7-9
Ruiz Feria, C.A.; Kidd, M.T.; Wideman, R.F. 1999: Plasma amino acid levels and growth performance of broilers fed supplemental L-arginine during cool temperature exposure. Poultry Science 78(Suppl 1): 56
Ribarova, F.; Vazelov, E.; Shishkov, S. 1999: Plasma amino acid ratios in hemodialysis patients on a protein supplemented diet. Amino Acids 17(1): 93
Mejia, A.; Horning, M.C.; Sanchez, A. 1999: Plasma amino acids discriminate between total vegetarians and nonvegetarians. American Journal of Clinical Nutrition 70(3 Suppl): 627S
Ivarsen, P.; Tietze, I.N.; Pedersen, E.B. 1999: Plasma amino acids in malnourished or well-nourished patients with severe chronic renal failure. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 76A
Weiss, M.; Krause, S.; Linnenbrock, M.; Liesen, H. 1999: Plasma amino acids profile and catecholamines at rest and after testing swimming performance during an annual season in competitive swimmers. Amino Acids 17(1): 107
Richards, A.M.; Lainchbury, J.G.; Troughton, R.W.; Nicholls, G.; Frampton, C.M.; Yandle, T.G. 2003: Plasma amino-terminal pro-B-type natriuretic peptide predicts postcardioversion reversion to atrial fibrillation. Journal of the American College of Cardiology 41(6 Suppl A): 99A
Haschke Becher, E.; Fazzolari, A.; Minoli, I.; Raiha, N.C.R.; Carrie, A.L.; Haschke, F.; Bachmann, C. 2000: Plasma aminoacids of infants fed modified whey formulas with protein-energy ratio of 18g/100kcal. JPGN 31(Suppl 2): S92
Micalos, P.; Marino, F.E.; Kay, D.; Tarpenning, K.; Gard, M. 1999: Plasma ammonia and lactate responses to isokinetic exercise. Medicine and Science in Sports and Exercise 31(5 Suppl): S161
Mehta, P.D.; Dalton, A.J.; Mehta, S.P.; Patrick, B.A.; Sersen, E.A.; Fedor, B. 2000: Plasma amyloid beta protein 1-42 levels are increased in old Down Syndrome but not in young DS. Neurology 54(7 Supp 3): A365-A366
Fischer, P.; Jellinger, K.; Jungwirth, S.; Weissgram, S.; Bauer, P.; Tragl, K.H. 2003: Plasma amyloid beta-peptide 1-42 and incipient Alzheimers dementia in the Vienna transdanube aging community. European Journal of Neurology 10(Suppl 1): 32
Rose, K.; Argoud Puy, G.; Baussant, T.; Bohm, G.; Botti, P.; Bougueleret, L.; Colinge, J.; Cusin, I.; Gaertner, H.; Jimenez, S.; Johnson, A.; Kussmann, M. 2002: Plasma analysis by proteomics. Molecular and Cellular Proteomics 1(9): 704
Ferdinandusse, S.; Overmars, H.; Denis, S.; Waterham, H.R.; Wanders, R.J.A.; Vreken, P. 2000: Plasma analysis of di- and trihydroxycholestanoic acid stereoisomers using HPLC tandem mass spectrometry and its application in peroxisomal alpha-methylacyl-CoA racemase deficiency. Journal of Inherited Metabolic Disease 23(Suppl 1): 256
Long, L.; Balis, F.M.; Mccully, C.; Moschel, R.C.; Dolan, M.E. 1999: Plasma and CSF pharmacokinetic study of 8-substituted O6-benzylguanines in nonhuman primates. Proceedings of the American Association for Cancer Research 40: 288
Shao, Q.; Yokoyama, W.; Watkins, S.M.; Baillie, R. 2004: Plasma and Tissue Lipids in Insulin Resistant Hamsters Fed High Fat and Fiber Diets. FASEB Journal 18(4-5): Abstract 112
Ryan, K.L.; Taylor, R.L.; Lehnert, H.M.; Mahajan, K.; Walters, T.J.; Mason, P.A. 1999: Plasma and adrenal catecholamines during 35-GHz microwave heating. FASEB Journal 13(5 Part 2): A743
Hiscock, N.; Blanchard, M.; Jenkins, D.; Mackinnon, L. 1999: Plasma and blood mononuclear cell glutamine concentrations after acute intense exercise. Medicine and Science in Sports and Exercise 31(5 Suppl): S60
Meng, Q.; Fasco, M.J.; Bellisario, R.; Kaminsky, L.; Pass, K.A.; Walker, V.E. 2001: Plasma and cellular markers of 3-azido-3-deoxythymidine metabolism as indicators of DNA incorporation of 3-azido-3-deoxythymidine in cord blood lymphocytes from infants exposed in utero. Environmental and Molecular Mutagenesis 37(Suppl 32): 53
Chen, W.; Gandhi, V.; Rhie, J.K.; Ayres, M.; Felix, E.; Newman, R.A. 2000: Plasma and cellular pharmacology of 8-chloro-adenosine in mice. Proceedings of the American Association for Cancer Research 41: 700
Chen, W.; Gandhi, V.; Ayres, M.L.; Madden, T.L.; Rhie, J.; Newman, R.A. 2001: Plasma and cellular pharmacology of 8-chloro-adenosine in rats. Proceedings of the American Association for Cancer Research 42: 80-81
Baker, D.G.; Ekhator, N.N.; Kasckow, J.W.; Hill, K.K.; Zoumakis, E.; Dashevsky, B.A.; Chrousos, G.P.; Geracioti, T.D.Jr 2001: Plasma and cerebrospinal fluid interleukin-6 concentrations in combat veterans with posttraumatic stress disorder. Neuroimmunomodulation 8(4): 216
Baker, D.G.; Ekhator, N.N.; Kasckow, J.W.; Hill, K.K.; Zoumakis, E.; Dashevsky, B.A.; Chrousos, G.P.; Geracioti, T.D. 2002: Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation 9(4): 209-217
Bednar, M.; Chieffo, C.; Morse, T.; Duplin, M.; Gibbs, M.A. 2004: Plasma and cerebrospinal fluid pharmacokinetics of CP-457,920, a selective alpha 5 GABA-A receptor inverse agonist in young, healthy volunteers. Clinical Pharmacology and Therapeutics 75(2): P30
Neville, K.; Parise, R.A.; Thompson, P.; Aleksic, A.; Egorin, M.J.; Balis, F.M.; McGuffey, L.; McCully, C.; Berg, S.L.; Blaney, S.M. 2004: Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(7): 2525-2529
Parise, R.A.; Mccully, C.M.; Balis, F.M.; Egorin, M.J. 2003: Plasma and cerebrospinal fluid pharmacokinetics of imatinib in non-human primates. Proceedings of the American Association for Cancer Research 44: 935
Kerr, J.Z.; Aleksic, A.; Mcguffey, L.; Douglas, J.; Berg, S.L.; Hausheer, F.; Blaney, S.M. 2000: Plasma and cerebrospinal fluid pharmacokinetics of karenitecin in nonhuman primates. Proceedings of the American Association for Cancer Research 41: 815
Jayaprakash, N.; Widemann, B.C.; Mccully, C.; Scanlon, E.; Balis, F.M. 2002: Plasma and cerebrospinal fluid pharmacokinetics of leucovorin and its active metabolite 5-methyltetrahydrofolate in non-human primates. Proceedings of the American Association for Cancer Research 43: 430
Moyle, G.J.; Sadler, M.; Buss, N. 1999: Plasma and cerebrospinal fluid saquinavir concentrations in patients receiving combination antiretroviral therapy. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 28(2): 403-404
Mayer Davis, E.J.; Costacou, T.; King, I.; Zaccaro, D.J.; Bell, R.A. 2001: Plasma and dietary vitamin E in relation to diabetes incidence The insulin resistance atherosclerosis study. Diabetes 50(Suppl 2): A39
Costacou, T.; Mayer Davis, E. 2003: Plasma and dietary vitamin E in relation to diabetic microalbuminuria Findings from the insulin resistance and atherosclerosis study and the San Luis Valley diabetes study. Diabetes 52(Suppl 1): A479
Perez, R.; Godoy, C.; Palma, C.; Cabezas, I.; Rubilar, L.; Arboix, M.; Alvinerie, M. 2003: Plasma and faecal profiles of doramectin after oral and intramuscular administration in horses. Journal of Veterinary Pharmacology and Therapeutics 26(Suppl 1): 90-91
Renaville, B.; Bacciu, N.; Comin, A.; Motta, M.; Poli, I.; Vanini, G.; Prandi, A. 2008: Plasma and follicular fluid fatty acid profiles in dairy cows. Reproduction in Domestic Animals 45(1): 118-121
George, M.; Baluch, M.; Van Thiel, D.H. 2002: Plasma and hepatic tissue measures of thrombomodulin, urokinase, no and NFkappaB in responders and non-responders to IFN alpha therapy administered for a HCV infection. Hepatology 36(4 Part 2): 596A
Pavlova, Z.V.; Laktionov, K.P.; Isakova, M.Y.; Kushlinsky, N.Y. 2000: Plasma and liquor beta-endorphine as a marker of analgesia efficiency in cancer patients with acute post-operative and chronic pain. Anesteziologiya i Reanimatologiya 2: 14-17
Green, M.P.; Hunter, M.G.; Mann, G.E. 2001: Plasma and luteal progesterone influence in vivo embryo development in day 5 post-estrus Holstein Friesian cows. Journal of Dairy Science 84(Suppl 1): 116
Herling, A.W.; Beha, A.; Neumann Haefelin, C.; Kuhlmann, J.; Belz, U.; Gerl, M.; Quint, M.; Biemer Daub, G.; Stein, M.; Kleinschmidt, E.; Kramer, W.; Juretschke, H.P. 2003: Plasma and muscle lipid parameters in Wistar and ZDF rats during fasting and refeeding. Diabetologia 46(Suppl 2): A216
Menchaca, H.J.; Michalek, V.; Rohde, T.D.; O'dea, T.J.; Hunninghake, D.; Buchwald, H. 1999: Plasma and red blood cell membrane cholesterol impacts red blood cell oxygen transport and myocardial oxygenation. Journal of the American College of Cardiology 33(2 Suppl A): 336A
Blazovics, A.; Hagymasi, K.; Lugasi, A.; Kovacs, A.; Feher, J. 2000: Plasma and red blood cell red-ox state a possible predictive factor in inflammatory bowel disease A chemiluminescence study. Journal of Hepatology 32(Suppl 2): 228
Gleeson, M.; Jeukendrup, A.E.; Blannin, A.K.; Bishop, N.C. 2000: Plasma and saliva cortisol responses to hill climbing in elite road race cyclists. Medicine and Science in Sports and Exercise 32(5 Suppl): S271
Wu, X.; Jackson, S. 2000: Plasma and salivary IgA and IgM antibodies in HIV-1-infected individuals. FASEB Journal 14(6): A942
Davenport, M.D.; Tiefenbacher, S.; Meyer, J.S.; Shannon, C.; Champoux, M.; Higley, J.D.; Suomi, S.J.; Novak, M.A. 2002: Plasma and salivary cortisol levels in differentially reared juvenile rhesus monkeys. American Journal of Primatology 57(Suppl 1): 66
Minniti, G.; Cerone, R.; Piana, A.; Armani, U.; Lorini, R. 2000: Plasma and serum total homocysteine concentrations in paediatric patients, evaluated by high-performance liquid chromatography with fluorescence. Clinical Chemistry and Laboratory Medicine 38(7): 675-676
Delacalle, J.; Burba, D.J.; Moore, R.M.; Hosgood, G.L.; Williams, J.; Leblanc, C.J. 2002: Plasma and synovial fluid nitric oxide and endothelin-1 concentrations in horses with normal and diseased joints. FASEB Journal 16(5): A973
Schutten, M.; Van Der Ende, M.E.; Tenner Racz, K.; Racz, P.; Niesters, H.G.M.; Osterhaus, A.D.M.E. 2000: Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals Implications for starting HAART. AIDS 14(Suppl 4): S3
Zamboni, W.C.; Jung, L.L.; Hamburger, D.R.; Jin, R.; Joseph, E.; Strychor, S.; Sun, S.L.; Egorin, M.J.; Eiseman, J.L. 2002: Plasma and tissue disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in mice bearing HT29 human colon xenografts. Proceedings of the American Association for Cancer Research 43: 247
Zamboni, W.; Jung, L.; Strychor, S.; Joseph, E.; Burke, T.; Curran, D.; Egorin, M.; Eiseman, J. 2003: Plasma and tissue disposition of DB-67 non-liposomal and bilayer liposomal in SCID mice. Proceedings of the American Association for Cancer Research 44: 350
Treska, V.; Racek, J.; Kuntscher, V.; Hasman, D.; Kobr, J.; Molacek, J.; Trefil, L.; Hes, O.; Reischig, T. 2002: Plasma and tissue levels of free oxygen radicals in recipients of kidneys from non-heart-beating donors: does recipient pretreatment with antioxidant drugs make sense? An experimental study in pigs. Transplantation Proceedings 34(8): 3060-3064
Gustafson, D.L.; Long, M.E.; Parpal, J.M.; Kerzic, P.J.; Carbone, D.L. 2001: Plasma and tissue pharmacokinetics of methotrexate and 7-OH-methotrexate in naive mice and mice previously treated with methotrexate. Proceedings of the American Association for Cancer Research 42: 382
Sartorio, A.; Conte, G.; Palmieri, E.; Resnik, M.; Vangeli, V.; Narici, M. 2000: Plasma and urinary GH following exercise in short children. Journal of Endocrinological Investigation 23(6 Suppl): 31
Cho, S.W.; Park, Y.O.; Cha, Y.S. 2003: Plasma and urinary carnitine concentrations in pregnant Korean women. FASEB Journal 17(4-5): Abstract 447
Pelikanova, T.; Simkova, R.; Jirsa, M. 2001: Plasma and urinary cytokine antagonists in type 1 diabetes mellitus. Diabetologia 44(Suppl 1): A316
Gbadegesin, R.A.; Cotton, S.A.; Coupes, B.M.; Brenchley, P.E.; Webb, N.J. 2001: Plasma and urinary soluble cell adhesion molecule expression is dysregulated in acute pyelonephritis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 169A
Flores, L.; Mur, C.; Simo, O.; Lario, S.; Inigo, P.; Esmatjes, E. 2001: Plasma and urinary transforming growth factor beta1 levels in patients with type 1 diabetes mellitus and microalbuminuria. Diabetologia 44(Suppl 1): A310
Prior, R.L.; Cao, G.; Hesslink, R.; Wise, J.; Askew, W.; Ensign, W.; Roberts, D. 2000: Plasma and urine antioxidant capacity in men during physical training while consuming a dietary antioxidant supplement. FASEB Journal 14(4): A520
Kinoshita, H.; Fujimoto, S.; Tokura, T.; Hisanaga, S.; Kitamura, K.; Eto, T. 1999: Plasma and urine levels of mature form of adrenomedullin in patients with chronic glomerulonephritis. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 455A
Pershing, R.A.; Thatcher, W.W.; Badinga, L. 2002: Plasma and uterine IGF-I and IGF-binding proteins in cyclic Holstein cows treated with bovine somatotropin. Biology of Reproduction 66(Suppl 1): 179
Hon, Y.en Yi; Jann, Michael, W. 2003: Plasma and whole blood histamine concentrations in healthy subjects with different histamine N-methyltransferase genotypes. Pharmacotherapy 23(10): 1357-1358
Pugh, P.J.; Jones, R.D.; Jones, T.H.; Channer, K.S. 2002: Plasma androgens and heart rate variability in men with heart failure. Clinical Science (London) 103(1): 6P
Hinojosa Laborde, C.; Silva, N.; Haywood, J.R.; Shade, R.; Imig, J.; Orengo, S. 2001: Plasma angiotensin II levels and angiotensin converting enzyme activity in ovariectomy-induced hypertension in Dahl salt sensitive rats. FASEB Journal 15(5): A1153
Brosnihan, K.B.; Karoly, M.; Merrill, D. 2000: Plasma angiotensin- is decreased in preeclampsia. Hypertension 36(4): 696
Li, Y.; Brandt Rauf, P.W.; Carney, W.P.; Tenney, D.Y.; Hamer, P.J.; Ford, J.G. 2000: Plasma anti-p53 antibodies and prognosis in lung cancer patients. Proceedings of the American Association for Cancer Research 41: 599
Garcia Castineiras, S.; Vasquez Quinones, L.; Perez, R.; Zapata, N.; Hernandez, L.; Chiesa, R. 2000: Plasma anticrystallin antibodies in diabetes type I. IOVS Investigative Ophthalmology and Visual Science 41(4): S97
Kriman, J.; Vasquez, R.; Leal, P.; Rivera, G.; Rodrigo, R. 2000: Plasma antioxidant capacity and antioxidant status of kidney are enhanced by chronic red wine consumption. Biocell 24(Suppl): 77
Floreani, A.; Baragiotta, A.; Martines, D.; Naccarato, R.; D'odorico, A. 1999: Plasma antioxidant levels in chronic cholestasic liver diseases. Hepatology 30(4 Part 2): 327A
Boonsiri, P.; Naowaratwattana, W.; Yongvanit, P.; Panthongviriyakul, C.; Kietchusakul, P.; Khampitak, T. 2000: Plasma antioxidant levels in premature Thai infants. Biochemical Society Transactions 28(5): A154
Facorro, G.; Sarrasague, M.M.; Piehl, L.; Freggiaro, E.; Faurie, R.; Hager, A. 2001: Plasma antioxidant status evaluation in patients with dietary acid ascorbic supplementation using electron spin resonance. Free Radical Biology and Medicine 31(10): S30
Fan, J.; Dwyer, K.M.; Nordstrom, C.K.; Merz, C.N.el Bairey; Dwyer, J.H. 2001: Plasma antioxidants and progression of carotid atherosclerosis The Los Angeles atherosclerosis Study. Circulation 104(17): 2; 806
Tamimi, R.; Hankinson, S.; Campos, H.; Spiegelman, D.; Zhang, S.; Colditz, G.; Willett, W.; Hunter, D. 2003: Plasma antioxidants and risk of breast cancer. American Journal of Epidemiology 157(11 Suppl): S15
Weintraub, J.M.; Willett, W.C.; Rosner, B.; Seddon, J.M.; Colditz, G.A.; Campos, H.; Hankinson, S.E. 2002: Plasma antioxidants and risk of cataract extraction. American Journal of Epidemiology 155(11 Suppl): S57
Pradhan, S.C.; Swain, S. 2000: Plasma antioxidants and schizophrenia. Schizophrenia Research 41(2): 383
Nagyova, A.; Huckova, M.; Kudlackova, M.; Magalova, T. 1999: Plasma antioxidative status and LDL oxidation in vegetarians. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S503
Blanc Bernard, E.; Verges, B.; Vaillant, G.; Petit, J.M.; Rudoni, S.; Gambert, P.; Brun, J.M. 2000: Plasma apolipoprotein A-IV in obesity. International Journal of Obesity 24(Suppl 1): S123
Kitiyakara, C.; Chabrashvili, T.; Welch, W.J.; Wilcox, C.S. 1999: Plasma arginine, NO generation, hepatic arginase and expression of cationic amino acid transporter Effects of salt intake. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 382A
Hilger, R.A.; Richly, H.; Strumberg, D.; Grubert, M.; Oberhoff, C.; Seeber, S.; Scheulen, M.E. 2002: Plasma as well as cellular pharmacokinetics of doxorubicin after application of pegylated liposomes A new option in the treatment of leukemia?. International Journal of Clinical Pharmacology and Therapeutics 40(8): 391
Toien, O.; Rice, M.E.; Barnes, B.M.; Drew, K.L. 1999: Plasma ascorbate and oxygen consumption during rewarming from hibernation in arctic ground squirrels. Society for Neuroscience Abstracts 25(1-2): 1844
Flourié, F.; Steghens, J.-P. 2004: Plasma ascorbic acid: preanalytical factors and new HPLC method. Annales de Biologie Clinique 62(3): 305-309
Batista, R.; Badré-Sentenac, S.; Bardin, C.; Chast, F. 2004: Plasma assay of methadone enantiomers with high performance liquid chromatography. Annales Pharmaceutiques Francaises 62(3): 193-200
Raitakari, O.T.; Paiva, H.; Laine, H.; Laaksonen, R.; Laakso, J.; Knuuti, J. 2001: Plasma asymmetric dimethylarginine and myocardial vasodilatory function in young subjects with borderline hypertension or familial hypercholesterolaemia. European Heart Journal 22(Abstract Suppl): 651
Fard, Ali; Donis, Joshua A.; Tuck, Catherine; Di Tullio, Marco R.; Wu, Henry; Huang, May L.; Chen, Niem Tzu; Torres Tamayo, Margarita; Ginsberg, Henry N.; Berglund, Lars; Homma, Shunichi; Cannon, Paul 1999: Plasma asymmetric dimethylarginine is elevated and endothelial function is impaired after a high-fat meal in type 2 diabetics. Circulation 100(18): 1; 701
Ebato, M.; Nakamura, Y.; Ebato, B.; Higashi, Y.; Tsutsumi, T.; Takeyama, Y. 1999: Plasma atrial and brain natriuretic peptides in patients with lone atrial fibrillation. European Heart Journal 20(ABSTR Suppl ): 219
Harada, K.; Nishimura, H.; Sonoda, M.; Takahashi, T. 2002: Plasma atrial natriuretic peptide and an immediate increase in the left ventricular stroke volume are two predictors of outcome of cardioversion. Circulation 106(19): 2; 683-II 684
Cappellin, Enrico; Gatti, Rosalba; Spinella, Paolo; De Palo, Carlo B.; Woloszczuk, Wolfgang; Maragno, Ildebrando; De Palo, Elio F. 2001: Plasma atrial natriuretic peptide fragments proANP and proANP measurements in chronic heart failure A useful index for heart transplantation?. Clinica Chimica Acta 310(1): 49-52, 1 August
Cappellin, E.; Meneghetti, M.; Lancerin, F.; Gatti, R.; Woloszczuck, W.; Santostasi, G.; Maragno, I.; De Palo, E.F. 1999: Plasma atrial natriuretic peptide fragments proANP proANP measurements in chronic heart failure. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S441
Kostis, J.B.; Klapholz, M.; Vesterqvist, O.; Delaney, C.L.; Liao, W.C.i 2000: Plasma atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin response to omapatrilat in heart failure. Journal of the American College of Cardiology 35(2 Suppl A): 206A
Quinn, J.F.; Silbert, L.; Kulhanek, D.; Dang, T.; Moore, M.; Kaye, J. 2003: Plasma beta amyloid 1-42 is stable over 8 weeks in Alzheimers patients initiating donepezil. Neurology 60(5 Suppl 1): A140-A141
Rose, J.; Wood, K.; Billingsley, J.; Olbertz, J.; Lovering, A.; Carr, J. 1999: Plasma beta-endorphin concentrations during natural and artifically induced winter hair growth in mink. Luger, Thomas A Author, Paus, Ralf Author, Lipton, James M Author, Slominski, Andrzej T Author Annals of the New York Academy of Sciences; Cutaneous neuroimmunomodulation: The proopiomelanocortin system 440-443
Arun, C.; Porter, K.E.; Mcmahon, G.; London, N.J.M.; O'byrne, K.; Hemingway, D.M. 2001: Plasma big ET-1 A tumour marker and surrogate marker for angiogenesis in lung cancer. British Journal of Cancer 85(Suppl 1): 33
Arun, C.; Porter, K.E.; London, N.J.M.; Hemingway, D.M. 2001: Plasma big ET-1 A tumour marker for upper gastro-intestinal tract cancers. Gut 48(Suppl 1): A51
Pazzi, P.; Puviani, C.M.; Brogli, M.; Guerra, G.; Gullini, S.; Morsiani, E. 2001: Plasma bile acid removal by high adsorption capacity resins. Hepatology 34(4 Pt 2): 192A
Wilkerson, C.; Vesci, J.; Geathers, D.; Storella, R.J. 1999: Plasma binding protein accelerates recovery from rocuronium blockade in rats. Anesthesiology 91(3A): A1050
Olayemi, F.; Adeshina, E. 2002: Plasma biochemical values in the African giant rat and the West African hinge backed tortoise. Veterinarski Arhiv 72(6): 335-342
M.C.nn, G.P.; Muir, D.F.; Macintyre, P.D.; Hillis, W.S. 2003: Plasma brain natriuretic peptide A prognostic marker in valvular aortic stensosis?. European Heart Journal 24(Abstract Suppl): 439
Kitaoka, H.; Okawa, M.; Kubo, T.; Yamasaki, N.; Matsumura, Y.; Furuno, T.; Doi, Y. 2003: Plasma brain natriuretic peptide and mortality in hypertrophic cardiomyopathy. Circulation 108(17): IV448
Kinoshita, M.; Horie, H.; Takahashi, M.; Izumi, M.; Tsutamoto, T.; Nakamura, Y. 1999: Plasma brain natriuretic peptide as a biochemical marker for physiological pacing. European Heart Journal 20(ABSTR Suppl ): 323
Omland, T.; Aakvaag, A.; Bonarjee, V.V.; Caidahl, K.; Dickstein, K.; Nilsen, D.W. 2000: Plasma brain natriuretic peptide as a prognostic indicator in patients with preserved left ventricular systolic function after acute myocardial infarction. Circulation 102(18): 2; 609
Davis, R.C.; Hobbs, F.D.R.; Roalfe, A.K.; Kenkre, J.E.; Hare, R.; Davies, M.K. 2000: Plasma brain natriuretic peptide assay is valuable in diagnosis of heart failure in the community, as well as in hospital. European Heart Journal 21(Abstract Suppl): 133
Tsutamoto, T.; Maeda, K.; Wada, A.; Mabuchi, N.; Hayashi, M.; Tsutsui, T.; Ohnishi, M.; Sawaki, M.; Fujii, M.; Matsumoto, T.; Matsui, T. 2000: Plasma brain natriuretic peptide concentration as a useful predictor of mortality and morbidity in patients with diastolic heart failure. Circulation 102(18): 2; 624
Nakamura, S.; Ishimori, M. 2001: Plasma brain natriuretic peptide concentration in patients with Graves' disease. Endocrine Journal 48(3): 403-404
Puddy, V.F.; Amirmansour, C.; Williams, A.F.; Singer, D.R.J. 2001: Plasma brain natriuretic peptide concentrations predict haemodynamically significant patent ductus arteriosus in preterm infants. Circulation 104(17): 2; 189
Redfield, M.M.; Rodeheffer, R.J.; Jacobsen, S.J.; Mahoney, D.W. 2003: Plasma brain natriuretic peptide for the detection of pre-clinical systolic dysfunction in the general population. Circulation 108(17): IV600-IV601
Yamazaki, H.; Senju, Y.; Kinoshita, N.; Katsukawa, F.; Onishi, S. 2000: Plasma brain natriuretic peptide in athletes. American Journal of Cardiology 85(11): 1393-1394
Adamson, D.L.; Brookes, C.I.O.; Kemp, M.; Hooper, J.; Harding, S.E.; Moat, N. 1999: Plasma brain natriuretic peptide levels correlate with clinical and cellular markers of cardiac function in patients undergoing surgery for mitral valve incompetence. European Heart Journal 20(ABSTR Suppl ): 561
Matsuda, N.; Endo, Y.; Uchida, Y.; Shimamura, K.; Shiga, T.; Kawana, M. 2000: Plasma brain natriuretic peptide levels predict tolerance to carvedilol in patients with severe heart failure. Circulation 102(18): 2; 627-II 628
Burgess, M.I.; Aziz, T.; El Gamel, A.; Ray, S.G.; Keevil, B.; Brooks, N.H.; Deiraniya, A.K.; Campbell, C.; Rahman, A.N.; Yonan, N. 1999: Plasma brain natriuretic peptide levels reflect the pattern of left ventricular filling after orthotopic heart transplantation Correlation with Doppler echocardiographic and haemodynamic findings. European Heart Journal 20(ABSTR Suppl ): 438
Kinugawa, T.; Kato, M.; Endo, A.; Osaki, S.; Ogino, K.; Igawa, O.; Hisatome, I.; Shigemasa, C. 2000: Plasma brain natriuretic peptide response to exercise is augmented in patients with left ventricular dysfunction and heart failure. Journal of the American College of Cardiology 35(2 Suppl A): 171A
Mikkelsen, K.V.; Ryde, H.; Videbaek, L.M.; Villadsen, H.D.; Bie, P.; Haghfelt, T. 2003: Plasma brain natriuretic peptide, myocardial performance index and coronary heart disease. European Heart Journal 24(Abstract Suppl): 436
Gonzalez, A.; Lopez, B.; Sanchez Del Pino, M.M.; Diaz, A.; Martin Raimundi, D.; Fortuno, M.A.; Tomas, L.; Lozano, E.; Hernandez, M.D. Mar; Sanchez, E.; Serrano, M.; Barba, J.; Querejeta, R.; Diez, J. 2003: Plasma cardiotrophin-1, a myocardial stress marker in hypertensive heart disease?. American Journal of Hypertension 16(5 Part 2): 85A
Wos, H.; Grzybowska Chlebowczyk, U.; Bujniewicz, E. 2001: Plasma carnitine concentration in children with classical coeliac disease. JPGN Journal of Pediatric Gastroenterology and Nutrition 32(3): 379
Wos, H.; Pawlik, J.; Grzybowska Chlebowczyk, U.; Pogorzelski, A.; Zebrak, J. 2001: Plasma carnitine concentration in children with cystic fibrosis. JPGN Journal of Pediatric Gastroenterology and Nutrition 32(3): 379
Simpson, D.; Katzenstein, D.; Millington, D.; Actg 291 Protocol Study Team 2000: Plasma carnitine in HIV-associated neuropathy Analysis of ACTG Protocol 291. Journal of Neurovirology 6(3): 259
Debska Slizien, A.; Owczarzak, A.; Lysiak Szydlowska, W.; Rutkowski, B. 2000: Plasma carnitine profile during erythropoietin treatment in hemodialysis patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 263A
Switzer, B.R.; Atwood, J.; Stark, A.; Hatch, J.; Travis, R.; Ullrich, F.; Wu, X.; Chiu, Y.; Smith, J.; Singletary, G.; Lyden, E. 2001: Plasma carotenoid, vitamin A and E levels in African Americans Age and smoking relationships. FASEB Journal 15(5): A958
Mceligot, A.J.; Rock, C.L.; Newman, V.; Sanborn, K.A.; Pierce, J.P. 1999: Plasma carotenoids and intakes at 3-yr follow-up in a feasibility study of high-vegetable diet to prevent breast cancer recurrence. FASEB Journal 13(4 Part 1): A554
Haegele, A.D.; Gillette, C.; O'neill, C.G.; Wolfe, P.; Heimendinger, J.; Sedlacek, S.; Thompson, H.J. 2000: Plasma carotenoids and oxidative DNA damage. Proceedings of the American Association for Cancer Research 41: 338-339
Lu, Q.; Hung, J.C.; Zhang, Z.F.; Scher, H.I.; Go, V.L.W.; Heber, D. 2000: Plasma carotenoids and risk of prostate cancer. FASEB Journal 14(4): A473
Van Kappel, A.L.; Martinez Garcia, C.; Elmstahl, S.; Steghens, J.P.; Chajes, V.; Bianchini, F.; Kaaks, R.; Riboli, E. 2001: Plasma carotenoids in relation to food consumption in Granada and Malmo. International Journal for Vitamin and Nutrition Research 71(2): 97-102
Heber, D.; Yip, I.; Go, V.L.W.; Liu, W.; Elashoff, R.M.; Lu, Q. 2000: Plasma carotenoids profiles in prostate cancer patients after dietary intervention. FASEB Journal 14(4): A719
Buffington, C.A.Tony 2000: Plasma catecholamine concentrations in cats with interstitial cystitis. Journal of Urology 163(4 Suppl): 59
Mulder, T.A.; Van Goor, C.A.; Blanco, C.E. 1999: Plasma catecholamine concentrations in response to acute hypoxia in the chick embryo. Pediatric Research 45(4 Part 2): 57A
Knirsch, W.; Schilling, F.H.; Pross, L.; Gonsinger, B.; Pump, B.; Hecker, W.; Holder, M.; Leichter, H. 2000: Plasma catecholamine levels during insulin-induced hypoglycemia A parameter for the diagnosis of growth hormone deficiency?. Acta Medica Auxologica 32(1): 37
Fanari, P.; Salvadori, A.; Bolla, G.; Fontana, M.; Giacomotti, E.; Saezza, A.; Brioschi, A.; Nibbio, F.; Longhini, E. 1999: Plasma catecholamines and respiratory exchange ratio during aerobic physical exercise in the obese subjects. International Journal of Obesity 23(Suppl 3): S73
Reims, H.M.; Fossum, E.; Hoieggen, A.; Eide, I.; Kjeldsen, S.E. 2003: Plasma catecholamines and responses to mental stress in young, borderline hypertensive men Contrast between lean and overweight individuals. American Journal of Hypertension 16(5 Part 2): 221A-222A
Sequeira, H.; Leman, S.; Bernet, F. 2000: Plasma catecholamines assay during autonomic dysreflexia in the chronic spinal cord-injured rat. European Journal of Neuroscience 12(Suppl 11): 420
Macedo, T.R.; Relvas, J.; Fontes Ribeiro CA; Pacheco, F.; Morgadinho, M.T.; Pinto, C.M.; Gomes, P.C.; Ventura, M.; Henriques, V.; Nunes, S.V.; Ruis, G.R.; Ramalheira, C.; Boto, I.; Vale, L.L. 2000: Plasma catecholamines during an ultrarapid heroin detoxification. Annals of the new York Academy of Sciences 914: 303-310
Boriani, G.; Biffi, M.; Pergolini, F.; Martignani, C.; Bargossi, A.; Zannoli, R.; Branzi, A. 2001: Plasma catecholamines during low energy internal atrial cardioversion and during electrophysiological study for induction of ventricular tachyarrhythmias. Journal of the American College of Cardiology 37(2 Suppl A): 96A
Goldstein, D.S.; Dendi, R.; Holmes, C. 2002: Plasma catecholamines in neurocardiogenic syncope and postural tachycardia syndrome. FASEB Journal 16(4): A117
Gruszecki, A.C.; Reddy, V.V.B. 2002: Plasma cell crystalline inclusions. Archives of Pathology and Laboratory Medicine 126(6): 755
Shapiro-Shelef, M.; Calame, K. 2004: Plasma cell differentiation and multiple myeloma. Current Opinion in Immunology 16(2): 226-234
Canani, L.H.; Warram, J.H.; Krolewski, A.A. 2001: Plasma cell differentiation antigen K121Q polymorphism and the development of end-stage renal disease in type 1 diabetes. Diabetes 50(Suppl 2): A173
Nagumo, H.; Agematsu, K.; Hokibara, S.; Shinozaki, K.; Kobayashi, N.; Komiyama, A. 2000: Plasma cell differentiation induced by CD27/CD70 interaction. Tissue Antigens 55(Suppl 1): 23
Carraway, H.; Ambinder, R.F. 2002: Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus. Current Opinion in Oncology 14(5): 543-545
Tampe, C.T.; Rivera Vazquez, C.; Ramirez Ronda, C.; Navarro, C.N.; Gonzalez, G.; Perales, M.; Saavedra, S. 2001: Plasma cell granuloma in the central nervous system of an HIV positive patient A case presentation and literature review. International Journal of Antimicrobial Agents 17(Suppl 1): S11-S12
Aksoy, P.K.; Ozdemir, B.H.; Aygün, C.; Agildere, M. 2001: Plasma cell granuloma of the testis: unusual localization. Journal of Urology 166(3): 1000
Betancourt, A.; Baldizon, C.; Ramirez Ronda, C.H. 2000: Plasma cell granuloma presenting as transverse myelitis in an HIV patient. Clinical Infectious Diseases 31(1): 256
Yamauchi, T.; Aso, K.; Lee, E.; Nakao, Y.; Akiyama, H.; Hino, M.; Sugano, Y.; Yasuda, S.; Shima, E.; Makita, K.; Aoyama, Y.; Nakamae, H.; Yamamura, R.; Tanaka, K.; Ohta, K.; Yamane, T.; Takubo, T.; Tatsumi, N. 2001: Plasma cell hyperplasia in a patient with methimazole-induced severe agranulocytosis. Journal of the Osaka City Medical Center 50(3-4): 187-189
Zhang, F.; Rebecca, O.B.; Maurizio, Z.; Lin, P. 2003: Plasma cell immunophenotype of paired peripheral blood and bone marrow samples in 11 myeloma patients. Modern Pathology 16(1): 261A
Candoni, A.; Tiribelli, M.; Fili, C.; Masolini, P.; Fanin, R. 2003: Plasma cell leukaemia following essential thrombocythemia treated with hydroxyurea and busulphan. British Journal of Haematology 121(Suppl 1): 27
Wols, H.A.M.nges; Underhill, G.W.; Kansas, G.S.; Witte, P.L. 2000: Plasma cell longevity is promoted by bone marrow stromal cells. FASEB Journal 14(6): A1185
Johnson, K.A.; Wennberg, C.; Hessle, L.; Mauro, S.; Goding, J.; Millan, J.L.; Terkeltaub, R. 1999: Plasma cell membrane glycoprotein-1 is a selective antagonist of tissue-nonspecific alkaline phosphatase in osteoblast-derived matrix vesicles. Journal of Bone and Mineral Research 14(Suppl 1): S352
Mathew, S.; Joseph, L.; Fassas, A.; Hough, A.J.; Gokden, M. 2003: Plasma cell myeloma involving cerebrospinal fluid 10-Year experience in a myeloma center. Modern Pathology 16(1): 243A-244A
Shinde, A.; Gokden, M.; Waldron, J.A.; Barlogie, B.; Joseph, L. 2002: Plasma cell myeloma presenting as mass lesion. Laboratory Investigation 82(1): 264A
Dong, H.Y.; Scadden, D.T.; De Leval, L.; Harris, N.L. 2000: Plasma cell neoplasms in HIV+ patients are aggressive tumors frequently associated with Kaposis sarcoma -associated herpes virus. Laboratory Investigation 80(1): 147A
Talley, P.; Watmore, A. 2003: Plasma cell specific fluorescence in situ hybridisation for multiple myeloma. Journal of Medical Genetics 40(Suppl 1): S56
Kang, C.J.; Yun, S.Y.; Kim, S.H.; Kim, Y.I.; Kim, D.J.; Kang, J.S.; Ham, E.S.; Hur, D.Y.; Cho, D.H.; Lee, K.M.; Chang, K.Y.; Kim, Y.B.; Lee, W.J. 2001: Plasma cell stage-specific J chain gene enhancer is critically dependent on the STAT-5 overlapping sequences. FASEB Journal 15(4): A696
Markey, G.M.; Connolly, N.; Morris, T.C.; Kettle, P.; Foster, H. 2001: Plasma cell subtypes in bone marrow biopsies from patients without plasma cell dyscrasia. British Journal of Haematology 114(4): 958-959
Cameron, M.; Morgan, J.; Cruickshank, D.J. 1999: Plasma cell vaginitis--a new clinical entity?. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 19(1): 91
Lo, Y.M.; Leung, S.F.; Chan, L.Y.; Lo, K.W.; Zhang, J.; Chan, A.T.; Lee, J.C.; Hjelm, N.M.; Johnson, P.J.; Huang, D.P. 2000: Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. Annals of the new York Academy of Sciences 906: 99-101
Craven, C.M.; Zhao, L.; Ward, K. 1999: Plasma cells accumulate in myometrium at sites of trophoblast cell invasion. Placenta 20(5-6): A 19
Chen Kiang, Selina 2003: Plasma cells and multiple myeloma. Immunological Reviews 194: 5-7
Balbontin, J.; Ferrer, M. 2002: Plasma chemistry reference values in free-living Bonellis Eagle nestlings. Journal of Raptor Research 36(3): 231-235
Church, H.J.; Hatton, C.E.; Cooper, A.; Moss, G.; Wraith, J.E. 2001: Plasma chitotriosidase activity as a marker of treatment efficacy in patients with Gaucher disease receiving enzyme replacement therapy. Journal of Inherited Metabolic Disease 24(Suppl 2): 161
Maccarone, C.; Pizzarelli, G.; Barone, R.; Musumeci, S. 2001: Plasma chitotriosidase activity is a marker of recovery in transplanted patients affected by beta-thalassemia major. Acta Haematologica 105(2): 109-110
Vollweiler, J.F.; Dumot, J.A.; Conwell, D.L.; Shay, S.; Van Lente, F.; Zuccaro, G. 2003: Plasma cholecystokinin levels increase immediately following ERCP and predict the degree of hyperamylasemia. American Journal of Gastroenterology 98(9 Suppl): S69
Braz, Delio, Jr; Gutierrez, Paulo S.; Da Luz, Protasio L. 2000: Plasma cholesterol does not predict fat plaque content A pathological study. Journal of the American College of Cardiology 35(2 Suppl A): 275A
Bos, H.; Laverman, G.D.; Henning, R.H.; De Jong, P.E.; De Zeeuw, D.; Navis, G.J. 2000: Plasma cholesterol modulates the antiproteinuric effect of ACE-inhibition in established adriamycin nephrosis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 614A
Buchman, A.L.; Ahn, C.; Ament, M.E.; Missra, S.; Choi, H.J.; Roch, M.; Jenden, D.J. 1999: Plasma choline concentrations in children requiring long-term home total parenteral nutrition A case control study. Gastroenterology 116(4 Part 2): A542
Omland, T.; Dickstein, K.; Syversen, U. 2000: Plasma chromogranin A is an independent predictor of survival after acute myocardial infarction. European Heart Journal 21(Abstract Suppl): 585
Sposito, A.C.; Dias Dos Santos Filho, R.; Amancio, R.F.; Maranhao, R.C. 1999: Plasma chylomicron-like emulsion removal is related to the plasma LDL cholesterol in patients with type IIa dyslipidemia. Circulation 100(18): 1; 257
Lutgens, L.C.H.W.; Von Meyenfeldt, M.F.; Deutz, N.E.P.; Lambin, P. 2000: Plasma citrulline A marker for gut metabolic derailment after whole abdominal radiation An experimental study in the rat. Radiotherapy and Oncology 56(Suppl 1): S181
Saksena, S.; Milkiewicz, P.; Cardenas, T.; Mills, C.O.; Elias, E.A. 1999: Plasma clearance of cholyl-lysyl-fluorescein in NASH reflects change in hepatic function with therapy. Hepatology 30(4 Part 2): 586A
Hine, R.J.; Zangari, M. 2002: Plasma cobalamin levels of patients with multiple myeloma. FASEB Journal 16(5): A747
Sagcan, A.; Kylync, E.; Kayapinar, D.; Kultursay, H.; Yalcin, A. 2002: Plasma coenzyme Q10 concentrations in patients with coronary atherosclerosis. European Heart Journal 23(Abstract Suppl): 565
Kitajima, M.; Higo, A. 1999: Plasma collecting device. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)
Gogic, S.; Nedeljkovic, N.; Antic, M.; Eric, B.; Gligorovic, V. 2000: Plasma collection Fractionation and clinical use. Vox Sanguinis 78(Suppl 1): P529
Antanavich, R.D.; Dorian, R. 2001: Plasma concentrate and method of processing blood for same. Official Gazette of the United States Patent and Trademark Office Patents 1245(2)
McCune, J.S.; Gibbs, J.P.; Slattery, J.T. 2000: Plasma concentration monitoring of busulfan: does it improve clinical outcome?. Clinical Pharmacokinetics 39(2): 155-165
Albert, M.A.; Glynn, R.J.; Ridker, P.M. 2003: Plasma concentration of C-Reactive Protein and physical activity. Journal of the American College of Cardiology 41(6 Suppl A): 319A
Fujioka, S.; Ono, Y.; Kangawa, K.; Okada, K. 1999: Plasma concentration of adrenomedullin is increased in hemorrhagic shock in dogs. Anesthesia and Analgesia 88(2): 326-328
Kawade, Y.; Ishii, J.; Watanabe, M.; Kasuga, H.; Yashima, A.; Yasuda, K.; Toriyama, T.; Kawahara, H.; Matsuo, S. 2002: Plasma concentration of brain natriuretic peptide is useful for risk stratification in hemodialysis patients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 589A
Muszczyński, Z.; Sulik, Młgorzata.; Ogoński, T.; Antoszek, J. 2010: Plasma concentration of calcium, magnesium and phosphorus in chinchilla with and without tooth overgrowth. Folia Biologica 58(1-2): 107-111
Albert, M.A.; Rifai, N.; Ridker, P.M. 2001: Plasma concentration of cystatin-C and mannose binding protein and the risk of developing peripheral vascular disease. Circulation 103(9): 1351
Koestering, M.; Schwartzkopff, B.; Mundhenke, M.; Strauer, B.E. 1999: Plasma concentration of endothelin in patients with myocardial diseases and high-grade cardiac arrhythmias in the 24-hour electrocardiogram. Annals of Hematology 78(Suppl 1): A69
Santell, R.C.; Kieu, N.; Helferich, W.G. 1999: Plasma concentration of genistein and food intake in mice fed varying amounts of genistein. FASEB Journal 13(5 Part 2): A885
Oransky, P.P.; Khanferyan, R.A.; Dubuske, L.M.; Oransky, S.P. 2004: Plasma concentration of interleukin-18 in acute myocardial infarction. Journal of Allergy and Clinical Immunology 113(2 Suppl): S325
Pradhan, A.D.; Manson, J.E.; Buring, J.E.; Ridker, P.M. 2001: Plasma concentration of interleukin-6 and C-reactive protein and the risk of developing type 2 diabetes mellitus among healthy middle-aged women. Circulation 103(9): 1351
Brown, D.A.; Breit, S.N.; Buring, J.; Fairlie, W.D.; Bauskin, A.R.; Liu, T.; Ridker, P.M. 2003: Plasma concentration of macrophage inhibitory cytokine-1 and the risk of cardiovascular events in women. European Cytokine Network 14(Suppl 3): 66
D.L.mos, J.A.; Hennekens, C.H.; Ridker, P.M. 1999: Plasma concentration of soluble vascular cell adhesion molecule-1 and the subsequent risk for myocardial infarction. Circulation 100(18): 1; 545
Hattori, Y.taka; Kakimoto, Tsunayuki; Okamoto, Shinichiro; Iguchi, Toyotaka; Morita, Kunihiko; Tanigawara, Y.suke; Ikeda, Yasuo 2003: Plasma concentration of thalidomide and clinical efficacy in patients with multiple myeloma. Blood 102(11): 689a
Boy, D.; Kinzig Schippers, M.; Soergel, F.; Well Naber, K.G. 2002: Plasma concentrations , urinary excretion and bactericidal activity of gatifloxacin 400 mg versus ciprofloxacin 500 mg in 12 healthy volunteers after a single oral dose. International Journal of Antimicrobial Agents 19(Suppl 1): S88
Edstein, M.D.; Kocisko, D.A.; Walsh, D.S.; Eamsila, C.; Sasiprapha, T.; Brewer, T.G.; Rieckmann, K.H.; Charles, B. 1999: Plasma concentrations and population modeling of tafenoquine during malarial chemosuppression in Thai soldiers. American Journal of Tropical Medicine and Hygiene 61(3 Suppl): 275
Celebi, F.; Güven, B. 2001: Plasma concentrations of 13,14-dihydro-15-keto PGF2alpha and progesterone during the oviposition cycle of the domestic goose (Anser anser domesticus). Poultry Science 80(2): 225-227
Moeckel, M.; Heller, G.; Logge, C.; Mueller, C.; Danne, O.; Frei, U.A. 2001: Plasma concentrations of Annexin V provide independent prognostic information in patients with unstable angina pectoris. Circulation 104(17): 2; 698
Wahl, H.; Graf, S.; Ashayer, S.; Scheckel, B.; Fassbinder, W.; Renz, H. 2004: Plasma concentrations of BNP and NT-proBNP in patients on hemodialysis. Clinical Chemistry 50(6, Suppl S, Part 2): A20-A21
Vos, P.L.A.M.; Perenyi, Z.; Jonker, F.H.; De Ruigh, L.; Van Wagtendonk, A.M.; Breukelman, S.; Soede, N.M.; Taverne, M.A.M.; Beckers, J.F.; Dieleman, S.J. 2001: Plasma concentrations of Bovine Pregnancy-Associated Glycoprotein during ongoing pregnancies after transfer of in vitro-produced bovine embryos. Theriogenology 55(1): 328
Mir, T.S.; Marohn, S.; Eiselt, M.; Haun, C.; Laer, S.; Laux, R.; Weil, J. 2002: Plasma concentrations of N-terminal brain natriuretic peptide in healthy children and in children with heart diseases. Circulation 106(19): 2; 450
Franz, M.; Woloszczuk, W.; Horl, W.H. 1999: Plasma concentrations of N-terminal fragments of proatrial natriuretic peptide in hemodialysis patients. Kidney and Blood Pressure Research 22(4-6): 230
Groenning, B.A.; Raymond, I.; Hildebrandt, P.R.; Pedersen, F.; Trawinski, J.; Baumann, M.; Nilsson, J.C. 2001: Plasma concentrations of N-terminal pro brain natriuretic peptide in the diagnosis of heart failure in the general population. European Heart Journal 22(Abstract Suppl): 395
Seino, Y.; Fukushima, M.; Fukumoto, H.; Wu, X. 2002: Plasma concentrations of N-terminal pro-BNP versus BNP in patients with chronic heart failure; more discerning marker for the progression. Circulation 106(19): 2; 683
Murgue, B.; Cassar, O.; Deparis, X. 1999: Plasma concentrations of SVCAM-1 in dengue patients Association with disease severity and epidemic patterns. American Journal of Tropical Medicine and Hygiene 61(3 Suppl): 212
Fleck, C.; Schweitzer, F.; Stein, G. 2002: Plasma concentrations of asymmetric and symmetric dimethylarginine in patients suffering from chronic renal failure in dependence on concomitant diseases. Kidney and Blood Pressure Research 25(3): 167
Semmekrot, B.; Pesman, G.; Span, P.; Sweep, F.; Van Heijst, A.; Monnens, L.; Van, D.B.r, M.; Tanke, R.; Van Der Staak, F. 1999: Plasma concentrations of atrial natriuretic peptide , plasma renin activity , aldosterone and arginine-vasopressin in neonates on extracorporeal membrane oxygenation. Pediatric Research 45(4 Part 2): 224A
Zhang, C.; Williams, M.A.; Sanchez, S.; King, I.B.; Ware Jauregui, S.; Laraburre, G.; Bazul, V.; Leisenring, W.M. 2000: Plasma concentrations of carotenoids, retinol and tocopherols in preeclamptic and normotensive pregnant women. American Journal of Epidemiology 151(11 Suppl): S10
Yamamoto, T.; Uchida, S.; Suzuki, Y.; Terada, H.; Watanabe, H.; Hayashi, H.; Ohashi, K.; Hashimoto, H. 2004: Plasma concentrations of class I antiarrhythmic drugs and their clinical effects. Journal of Pharmacological Sciences 94(Suppl 1): 271P
Falkenhorst, G.; Schubert, S.; Leonhardt, U.; Engelmann, L. 2001: Plasma concentrations of cytokines and other systemic inflammatory markers in three patients with complicated malaria tropica. Infection 29(Suppl 1): 49
Ohashi, H.; Oda, H.; Ohno, M. 2000: Plasma concentrations of cytokines and the risk of cardiovascular events in CAPD patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 215A
Boudou, P.; Hispard, E.; Dally, S.; Vincens, M.; Girre, C. 2002: Plasma concentrations of dehydroepiandrosterone sulfate in male chronic alcoholic patients Effect of withdrawal. Alcoholism Clinical and Experimental Research 26(5 Suppl): 148A
Guay, D.R. 2003: Plasma concentrations of desethyloxybutynin , the primary active metabolite of oxybutynin , are inversely related to salivary production. Clinical Pharmacology and Therapeutics 73(2): P49
Selzsam, B.; Niemann, L.; Wittfoht, W.; Chahoud, I. 2002: Plasma concentrations of estradiol, testosterone, T3 and T4 in 16-week-old Japanese quail. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R156
Soeki, T.; Tamura, Y.; Shinohara, H.; Sawada, Y.; Fukuda, N. 2001: Plasma concentrations of fibrinolytic factors in the subacute phase of acute myocardial infarction predict recurrence of myocardial infarction. Journal of the American College of Cardiology 37(2 Suppl A): 355A
Mazoit, J.X.; Labaille, T.; Paqueron, X.; Benhamou, D. 1999: Plasma concentrations of intraperitoneal ropivacaine for cholecystectomy. Anesthesiology 91(3A): A895
Browning, R.; Gissendanner, S.J.; Jenkins, D.; Wakefield, T. 1999: Plasma concentrations of metabolic regulatory hormones in cows treated with ergotamine. Diabetes 48(Suppl 1): A427
Gerasimovska, B.; Zafirovska, K.; Maleska, V.; Dejanova, E.; Bogdanovska, S.; Lozance, L.; Paneva Masin, E. 1999: Plasma concentrations of nitric oxide in patients with essential hypertension. Nephrology Dialysis Transplantation 14(9): A67
Demers, A.; Ayotte, P.; Dewailly, E.; Brisson, J.; Dodin, S.; Robert, J. 2001: Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer A congener specific analysis. American Journal of Epidemiology 153(11 Suppl): S203
Drescher, S.; Glaeser, H.; Muerdter, T.; Eichelbaum, M.; Fromm, M.F. 2003: Plasma concentrations of quinidine are determined by intestinal P-glycoprotein and CYP3A4 in humans. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R114
Hasegawa, G.; Ohta, M.; Shigeta, H.; Shigeta, M.; Tanaka, T.; Yamaguchi, M.; Obayashi, H.; Yamasaki, M.; Fukui, M.; Nakamura, N.; Yoshikawa, T. 2003: Plasma concentrations of resistin in type 2 diabetic patients. Diabetes 52(Suppl 1): A82-A83
Claussen, P.; Jacobsen, P.; Rossing, K.; Jensen, J.S.; Parving, H.H.; Feldt Rasmussen, B. 1999: Plasma concentrations of soluble adhesion molecules in insulin dependent diabetes mellitus The impact of early diabetic nephropathy. Diabetes 48(Suppl 1): A134
Moehler, T.M.; Goldschmidt, H.; Neben, K.; Kasper, B.; Hawighorst, H.; Van Kaick, G.; Benner, A.; Reusch, P.; Ho, A.D.; Marme, D.; Drevs, J. 2001: Plasma concentrations of soluble endothelial specific tyrosine kinase receptors correlate with disease activity markers and functional magnetic resonance imaging parameters in multiple myeloma. Blood 98(11 Part 2): 301b-302b
Wakabayashi, S.; Aso, Y.; Okumura, K.I.; Inukai, Y.; Matsutomo, R.; Takebayashi, K.; Takemura, Y.; Inukai, T. 2003: Plasma concentrations of total homocysteine are associated with endothelial dysfunction in patients with type 2 diabetes A possible link between diabetic nephropathy and macroangiopathy. Diabetes 52(Suppl 1): A170
Bøtker, H.E.; Ingerslev, J. 2000: Plasma concentrations of von Willebrand factor in patients with angina pectoris secondary to coronary atherosclerosis or cardiac syndrome X. Thrombosis Research 97(6): 519-523
Wagenlehner, F.M.E.; Wydra, S.; Onda, H.; Kinzig Schippers, M.; Soergel, F.; Naber, K.G. 2002: Plasma concentrations, urinary excretion and bactericidal activity of linezolid versus ciprofloxacin in healthy volunteers after a single oral dose. International Journal of Antimicrobial Agents 19(Suppl 1): S32
Lloyd Wright, Z.; Key, T.J.A.; Allen, N.; Sanders, T.A.B. 2003: Plasma conjugated linoleic acid concentrations in vegan, vegetarian and omnivore men recruited into the EPIC study 9-cis, 11 trans octadecadienoic acid are markers for the intake of ruminant derived fat. Proceedings of the Nutrition Society 62(OCA-B): 42A, Autumn
Mac Neil, S.; Haddow, D.; France, R.; Beck, A.; Dawson, R.; Philips, J.; Short, R. 2001: Plasma copolymer surfaces for culture of keratinocytes for clinical use. British Journal of Dermatology 144(3): 669
Love, O.P.; Bird, D.M.; Shutt, L. 2003: Plasma corticosterone in captive sibling American kestrels Effects of age, hatching order and hatching asynchrony. SICB Annual Meeting and Exhibition Final Program and Abstracts : 232
Fernandez Real, J.M.; Grasa, M.; Casamitjana, R.; Pugeat, M.; Barret, C.; Ricart, W. 1999: Plasma cortisol binding globulin levels are associated with insulin secretion. Diabetologia 42(Suppl 1): A190
Taylor, R.L.; Bonnes, B.; Halbach, A.; Lee, A.; Singh, R.J. 2002: Plasma cortisol by LC-MS/MS. Clinical Chemistry 48(6 Suppl): A131-A132
Sakkinen, H.; Stien, A.; Holand, O.; Hove, K.; Eloranta, E.; Saarela, S.; Ropstad, E. 2000: Plasma creatinine concentration in semi-domestic free ranging reindeer, and in reindeer under defined feeding conditions. Advances in Ethology 35: 76
Zamora, P.O.; Chen, M.; Osaki, S.; Hsieh, T.T.; Tsang, R. 2004: Plasma cross-linked hydrophilic coating. Official Gazette of the United States Patent and Trademark Office Patents 1284(3)
Karavolias, G.K.; Iliodromitis, E.K.; Markianos, M.; Theodorakis, G.N.; Kyriakides, Z.S.; Apostolou, T.; Kremastinos, D.T. 1999: Plasma cyclic-GMP A marker of infarct-related artery patency?. European Heart Journal 20(ABSTR Suppl ): 514
Van Bel, F.; Valk, L.; Egberts, J.; Krediet, T.G. 2001: Plasma cyclic-guanosine monophosphate is positively related to severity of peri/intraventricular hemorrhage in the premature infant. Pediatric Research 49(4 Part 2): 442A
L.B.icon, T.; Thervet, E.; Froissart, M.; Benlakehal, M.; Bousquet, B.; Legendre, C.; Erlich, D. 2000: Plasma cystatin C A better marker of glomerular filtration rate than creatinine in kidney transplantation. Clinical Biochemistry 33(3): 232
L.B.icon, T.; Thervet, E.; Viguier, D.; Benlakehal, M.; Filliol, B.; Bedrossian, J.; Legendre, C.; Beuzard, Y.; Erlich, D. 1999: Plasma cystatin C An alternative marker of graft function following kidney transplantation. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S343
Cianciolo, G.; De Pascalis, A.; Iannelli, S.; Donati, G.; Isola, E.; Manna, C.; Zambianchi, L.; Coli, L.; Stefoni, S. 2000: Plasma cytokine imbalance in HD patients with cardiovascular diseases. Nephrology Dialysis Transplantation 15(9): A212
Cianciolo, G.; Donati, G.; Coli, L.; D'addio, F.; Grammatico, F.; Dalmastri, V.; Stefoni, S. 2002: Plasma cytokine imbalance is a risk factor for atherosclerosis disease in dialysis patients. International Journal of Artificial Organs 25(7): 662
Proffitt, J.M.; Tejero, M.E.; Freeland Graves, J.H.; Cole, S.A.; Comuzzie, A.G. 2003: Plasma cytokine measures reflect variations in adiposity and glucose metabolism in baboons. FASEB Journal 17(4-5): Abstract 194
Downs, L.G.; Bolton, C.H.; Victory, J.; Tomson, C.R.V.; Dwight, J.S.F.; Pinkney, J.H. 2000: Plasma cytokines are elevated in chronic renal failure and are related to risk factors for cardiovascular disease. Journal of Endocrinology 164(Suppl ): P157
Mcnamara, D.M.; Starling, R.; Dec, G.W.; Loh, E.; Torre Amione, G.; Tokarczyk, T.R.; Janosko, K.M.; Holubkov, R. 2000: Plasma cytokines in acute cardiomyopathy Evolution over time, correlations with functional studies, and potential role in recovery. Circulation 102(18): 2; 415
Madorin, W.S.; Cepinskas, G.; Kvietys, P.R. 2002: Plasma derived from mice subjected to cecal ligation and perforation can activate cardiac myocytes Role of NFkappaB and cytokines. FASEB Journal 16(4): A593
Adams, D.F.; Sellers, T.S.; Ennulat, D.; Schwartz, L.W. 2002: Plasma dermatan sulfate A sensitive marker of antithrombotic activity in cynomolgus monkeys. Clinical Chemistry 48(6 Suppl): A77-A78
Kamel, L.N.; Akl, S.; Bibawi, H.; Kahla, H. 2002: Plasma des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers of hepatocellular carcinoma. Clinical Chemistry 48(6 Suppl): A20
Pickford, D.B.; Guillette, L.J.Jr; Crain, D.A.; Rooney, A.A.; Woodward, A.R. 2000: Plasma dihydrotestosterone concentrations and phallus size in juvenile American alligators from contaminated and reference populations. Journal of Herpetology 34(2): 233-239
Johnson, B.M.; Babcock, W.C.; West, J.B.; Friesen, D.T. 2001: Plasma discharge reactors for the preparation of bioactive compounds. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)
Sanchez, S.F.; Jones, D.G.; Small, J.N.W.; Boggio, J.C.; Mckellar, Q.A. 2000: Plasma disposition kinetics of oxfendazole given intravenously to sheep at three different concentrations. Drug Metabolism Reviews 32(Suppl 1): 101
Olivero, O.A.; Reddy, M.; Pietras, S.M.; Poirier, M.C. 2000: Plasma drug levels compared to genotoxicity in adult cynomolgus monkeys exposed to 3-azido-3-deoxythymidine. Environmental and Molecular Mutagenesis 35(Suppl 31): 46
Olivero, O.A.; Reddy, M.K.; Pietras, S.M.; Poirier, M.C. 2001: Plasma drug levels compared with DNA incorporation of 3-azido-3-deoxythymidine in adult cynomolgus monkeys. Experimental Biology and Medicine (Maywood) 226(5): 446-449
Mathrubutham, M.; Aybek, Z.; Fogarty, J.; Lee, J.; Rao, S.K.; Badlani, G.H.; Kushner, L. 1999: Plasma elastase regulation in stress urinary incontinence. Neurourology and Urodynamics 18(4): 281-282
Pervin, F.; Helal, R.; Biswas, K.B.; Chowdhury, T.A.; Ali, L. 2002: Plasma electrolytes in patients of Preeclamptic toxemia with and without diabetes. Diabetologia 45(Suppl 2): A 395
Harris, M.C.; Kaufman, D.; Evans, J.; Corcoran, L.; Zirin, S.; Kilpatrick, L. 2000: Plasma elevations of the chemokines IL-8 and ENA-78 in neonatal sepsis and necrotizing enterocolitis. Pediatric Research 47(4 Part 2): 341A
Trombino, C.; Rapaccini, G.L.; Sciamanna, V.; Sanalitro, M.; Covino, M.; Matera, A.; Menini, E.; Gasbarrini, G. 1999: Plasma endothelin 1 level in cirrhotic patients without ascites Relationship with intrarenal resistance index. Journal of Hepatology 30(Suppl 1): 197
Grekas, D.; Bamichas, G.; Karamouzis, M.; Bacharaki, D.; Savidis, N.; Tourkantonis, A. 1999: Plasma endothelin in cyclosporine A-treated renal transplant patients. Transplantation Proceedings 31(3): 1703-1705
Saadi, M.G.; Hassaballah, N.; El Ghoneimy, E. 2000: Plasma endothelin level in renal transplant patients. Nephrology Dialysis Transplantation 15(9): A248
He, S.D.; Qi, H.; Qin, J. 2001: Plasma endothelin levels and plasminogen activator inhibitor activities in patients with essential hypertension combined with diabetes mellitus. American Journal of Hypertension 14(4 Part 2): 65A-66A
Hussein, M.Y.; El Monim, M.T. Abd; Elsaid, M.H.; El Rasad, M.; Ibrahim, H.K. 2001: Plasma endothelin levels in congenital heart disease. Pediatric Research 49(4 Part 2): 36A
Laffer, C.L.; Schiffrin, E.L.; Gavras, H.; Elijovich, F. 2000: Plasma endothelin of sibpairs Variability, inheritance, and linkage to obesity in essential hypertension. Hypertension 36(4): 725
Papp, F.; Sallay, E.; Bereczki, C.; Haszon, I.; Turi, S. 1999: Plasma endothelin, platelet aggregation and thromboxane release in progressive renal diseases and in essential hypertension. Pediatric Nephrology 13(7): C54
Fujimori, K.; Yamada, J.; Ishida, T.; Anzai, K.; Honda, S.; Sanpei, M.; Asano, K.; Takanashi, A.; Okawa, T.; Yanagida, K.; Sato, A. 1999: Plasma endothelin-1 and atrial natriuretic peptide levels during prolonged hypoxemia in fetal goats. American Journal of Obstetrics and Gynecology 180(1 Part 2): S119
Hirai, Y.ji; Adachi, Hisashi; Fujiura, Yoshihisa; Satoh, Akira; Imaizumi, Tsutomu 2001: Plasma endothelin-1 and hypertension An epidemiological study. Circulation 104(17): 2; 792
Soelaeman, M.R.; Supandiman, I.; Idjradinata, P.; Nurhalim, S.M. 2001: Plasma endothelin-1 and inositol 1,4,5 triphosphate in monocyte levels in low renin essential hypertension. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 246A
Abdel Hady, H.; El Sallab, Sh; Sarhan, A.; Mansour, A.; Abu Hashim, I.; El Hassanin, A. 2001: Plasma endothelin-1 concentrations in severe perinatal asphyxia. Pediatric Research 49(2): 306
M.C.nn, G.P.; Muir, D.F.; Macintyre, P.D.; Hillis, W.S. 2001: Plasma endothelin-1 falls after maximal exercise in symptomatic but not asymptomatic aortic stenosis. European Heart Journal 22(Abstract Suppl): 492
El-Gamal, Y.; Hossny, E.; Awwad, K.; Mabrouk, R.; Boseila, N. 2002: Plasma endothelin-1 immunoreactivity in asthmatic children. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 88(4): 370-373
Bakr, Am; Abdalla, Ahmed; Amer, Talal; El Marsafawy, Hala; El Regal, Mohammed Ezz; Abu Hashim, I.; Abdel Khalik, Mohammed K.; A.Kader, Hassan H. 2002: Plasma endothelin-1 levels in children with cirrhosis Relationship to renal function and the severity of portal hypertension. Gastroenterology 122(4 Suppl 1): A 654
Khalil, T.; Abou El Ella, S.; Hasan, F.; El Gendy, F. 2001: Plasma endothelin-1 levels in children with congenital heart diseases. European Heart Journal 22(Abstract Suppl): 427
Bruno, C.M.; Neri, S.; Scuderi, R.; Caruso, L. 1999: Plasma endothelin-1 levels in patients with cirrhosis of the liver. Hepatology 30(4 Part 2): 262A
Mora Rodriguez, R.; Coyle, E.F. 1999: Plasma epinephrine reduces blood glucose clearance during low intensity exercise. Medicine and Science in Sports and Exercise 31(5 Suppl): S126
Wolf, R.B.; Moise, K.J.; Widness, J.A.; Brace, R.A. 2000: Plasma erythropoietin and iron concentrations in the ovine fetus with immune-induced hemolytic anemia. American Journal of Obstetrics and Gynecology 182(1 Part 2): S174
Baruselli, P.S.; Marques, M.O.; Arruda, R.P.; Carvalho, N.A.T.; Oliveira, C.A. 2002: Plasma estradiol and progesterone concentrations in superovulated buffalo in presence of CIDR-B devices. Theriogenology 57(1): 761
Geerlings, Mirjam I.; Launer, Lenore J.; De Jong, Frank H.; Hofman, Albert; Witteman, Jacqueline C.M.; Pols, Huib A.P.; Breteler, Monique M.B. 2001: Plasma estradiol and risk of dementia in older women and men. Neurology 56(8 Suppl 3): A242
Stegmayr, B.G.; Banga, R.; Berggren, L.; Norda, R.; Rydvall, A.; Vikerfors, T. 2001: Plasma exchange as rescue therapy in multi-organ failure including acute renal failure. Nephrology Dialysis Transplantation 16(6): A89
Abdo, A.S..; Cook, D.J..; Mccarthy, J.F..; Bishay, E.S..; Kumpati, G.S..; Starling, R.C..; Young, J.B..; Koo, A.P..; Smedira, N.G..; McCarthy, P.M.. 2001: Plasma exchange before and after cardiac transplantation. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 20(2): 194
Hill, C.E.; Lankford, K.V.; Brown, W.V.; Duncan, A.; Hillyer, C.D. 1999: Plasma exchange for elevated lipoprotein in a patient with xanthoma disseminatum. Transfusion 39(10 Suppl): 9S
Agarwal, K.; Thomas, N.; Taneja, V.; Beri, R.S.; Khanduri, U.; Puliyel, J.M. 2002: Plasma exchange in a child with systemic lupus erythematosus antiphospholipid antibodies and profound deafness. Annals of Tropical Paediatrics 22(1): 109-110
Boctor, F.N.; Ali, N.M.; Blake, M. 2000: Plasma exchange in the treatment of AIDS patients with conditions associated with thrombotic thrombocytopenic purpura and autoantibody production. Annals of Clinical and Laboratory Science 30(3): 317
Pajares, A.L.; Trentadue, J.C.; Galli, A.C.; Reybaud, J.F.; Gongora, G.N.; Salamone, H.J. 2000: Plasma exchange therapy in fulminant Wilsons disease. Vox Sanguinis 78(Suppl 1): P222
Courtois, Fçoise.; Coffe, C.; Coppo, P.; Korach, J-Michel.; Tremisi, J-Pierre.; Bussel, A.; Driss, Fçoise.; Guidet, B.; Piquet, Y.; Pourrat, J.; Riffle, Gérard.; Veyradier, Aès.; Vignon, D. 2002: Plasma exchanges and replacement fluids for adult thrombotic microangiopathy. Synopsis of the Round table held on May 3, 2001. Annales de Medecine Interne 153(6): 416-418
Adachi, T.; Masuda, K.; Hara, H.; Yamamoto, M.; Mitsui, N.; Oh-ishi, T.; Okazaki, M. 2000: Plasma extracellular-superoxide dismutase in healthy newborns and infants/children. Clinica Chimica Acta; International Journal of Clinical Chemistry 295(1-2): 203-205
Wang, L.; Folsom, A.R.; Zheng, Z.J.; Pankow, J.S.; Eckfeldt, J.H. 2002: Plasma fatty acid composition and incidence of diabetes in middle aged adults The atherosclerosis risk in communities study. Circulation 106(19): 2; 731
Trebble, T.; May, A.; Wootton, S.A.; Erlewyn Lajeunesse, M.D.S.; Chakraborty, A.; Mullee, M.A.; Stroud, M.A.; Beattie, R.M. 2003: Plasma fatty acid composition and nutritional status in paediatric Crohns disease. Gut 52(Suppl 1): A98
Lee, W.P.; Mao, C.S.; Bassilian, S.; Lim, S.; Ahmed, S.; Boros, L.G. 2001: Plasma fatty acid production and the role of de novo lipogenesis in energy transport. Journal of Investigative Medicine 49(1): 51A
Bederova, A.; Kudlackova, M.; Beder, I.; Babinska, K.; Klvanova, J.; Magalova, T.; Brtkova, A. 1999: Plasma fatty acids in two iron level groups of children. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S254
Mora Rodriguez, R.; Hodgkinson, B.J.; Byerley, L.O.; Coyle, E.F. 2000: Plasma fatty acids levels influence plasma glucose disappearance during exercise with beta-adrenergic blockade. Medicine and Science in Sports and Exercise 32(5 Suppl): S259
Koenig, W.; Rothenbacher, D.; Hoffmeister, A.; Bode, G.; Griesshammer, M.; Brenner, H. 2000: Plasma fibrin D-dimer levels and risk of coronary artery disease Results of a large case-control study. European Heart Journal 21(Abstract Suppl): 611
Youngman, L.D.; Keavney, B.D.; Palmer, A.; Parish, S.; Clark, S.; Danesh, J.; Delepine, M.; Lathrop, M.; Peto, R.; Collins, R. 2000: Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls Test of causality by Mendelian randomisation. Circulation 102(18): 2; 31-II 32
Kalani, M.; Fagrell, B.; Jorneskog, G. 2000: Plasma fibrinogen is related to foot ulcer area and transcutaneous oxygen tension in patients with type 2 diabetes and macroangiopathy. Diabetologia 43(Suppl 1): A245
Borawski, J.; Myśliwiec, M. 2001: Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients. Clinical and Applied Thrombosis/Hemostasis: Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 7(4): 296-299
Mohammad, Y.M.; Qureshi, A.I.; Suri, M.F.reed K.; Guterman, L.R.; Hopkins, N.L. 2000: Plasma fibrinogen levels and the likelihood of non-fatal stroke and myocardial infarction Data from the Third National Health and Nutrition Examination Survey. Neurology 54(7 Supp 3): A141
Metzger, T.; Zimmermann, J.; Herfs, K.; Wanner, C. 2000: Plasma fibrinogen levels, the G-455-A polymorphism of the beta-fibrinogen gene and their influence on mortality rate in hemodialysis patients. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 288A
Assanelli, D.; Ferrari, R.; Iacoviello, L.; Di Castelnuovo, A.; Galeazzi, G.L.; Boldini, A.; Albertini, F.; Maccalli, P.; Brentana, L.; Ascari, L. 2002: Plasma fibrinogen variability in healthy citizens. Thrombosis Research 108(5-6): 287-289
Jacob, K.; Talwar, S.; Copplestone, A.; Gilbert, T.; Haywood, G. 2001: Plasma fibrinogen, antithrombin III, protein C and D-dimers in patients with chronic atrial fibrillation Effects of electrical cardioversion in the short and medium term. Circulation 104(17): 2; 730-II 731
Famodu, A.A.; Fakoya, T.A.; Odusoga, O.L.; Fakoya, E.A.O.; Osilesi, O. 1999: Plasma fibrinogen, plasma viscosity in African women on oral contraceptive pills with sickle-cell trait. Biorheology 36(1-2): 92-93
Evans, J.M.; Mcintosh, C.M.; Kim, C.S.; Leonelli, F.A.; Ertl, A.C.; Knapp, C.F. 2003: Plasma filtration in healthy volunteers and patients with unexplained syncope. FASEB Journal 17(4-5): Abstract
Evans, J.M.; Mcintosh, C.M.; Patwardhan, A.R.; Leonelli, F.M.; Knapp, C.F. 2000: Plasma filtration rate and syncope in young healthy people during lower body negative pressure. FASEB Journal 14(4): A57
Lin, J.; Tzeng, C.; Hu, H.; Liu, L.; Yi, M.; Yung, C. 1999: Plasma filtration therapy without recovery of residual plasma in the filter in the treatment of myasthenia gravis. Transfusion 39(10 Suppl): 11S
Ichimura, H.; Parthasarathi, K.; Bhattacharya, J. 2003: Plasma flow determines pressure-induced leukocyte accumulation in lung venular capillaries. FASEB Journal 17(4-5): Abstract 346
Hase, I.; Oda, Y.; Imaoka, S.; Funae, Y.; Asada, A. 1999: Plasma fluoride following general anesthesia can be predicted by CYP2E1 mRNA in mononuclear cells. Anesthesiology 91(3A): A405
Mcglynn, K.A.; Obroin, S.; N'dao, M.; Chen, G.; Buetow, K.H.; Shen, F.M.; London, W.T. 1999: Plasma folate, chronic HBV infection and primary liver cancer. Proceedings of the American Association for Cancer Research 40: 149-150
Edland, S.D.; Klee, G.G.; Rinaldo, P.; Boeve, B.F.; Wai, D.T.; Ivnik, R.J.; Smith, G.E.; Tangalos, E.G.; Petersen, R.C. 2004: Plasma folate, plasma homocysteine, and risk of mild cognitive impairment or dementia. American Journal of Epidemiology 159(11, Suppl S): S63
Sanchez, S.E.; Zhang, C.; Malinow, M.R.; Ware Jauregui, S.; Larrabure, G.; Williams, M.A. 2000: Plasma folate, vitamin B12 and homocyst ine in preeclamptic and normotensive women. American Journal of Epidemiology 151(11 Suppl): S9
Zhang, S.M.; Willett, W.C.; Selhub, J.; Hunter, D.J.; Giovannucci, E.L.; Holmes, M.D.; Colditz, G.A.; Hankinson, S.E. 2002: Plasma folate, vitamin B6, vitamin B12, and homocysteine and the risk of breast cancer. Proceedings of the American Association for Cancer Research 43: 242-243
Weingaertner, J.; Bienengraeber, V.; Kundt, G.; Fanghaenel, J. 2003: Plasma folic acid concentrations of growing rats. Tieraerztliche Umschau 58(1): 651-652, 1 Dezember
Kadziela, J.; Janas, J.; Gazdzik, D.; Dzielinska, Z.; Piotrowski, W.; Chotkowska, E.; Ruzyllo, W. 2003: Plasma folic acid level may be a risk factor for coronary artery disease independently of homocysteine concentrations. European Heart Journal 24(Abstract Suppl): 672
Allen, D.; Butt, A.; Wheeler, M.; Cahill, D.; Popert, R.; Swaminathan, R. 2004: Plasma free DNA levels offer a sensitive and specific test to distinguish between benign and malignant prostate disease. European Urology Suppls 3(2): 24
Allen, D.J.; Butt, A.; Cahill, D.; Wheeler, M.; Swaminathan, R.; Popert, R. 2004: Plasma free DNA offers a sensitive and specific test for prostate cancer. Journal of Urology 171(4 Suppl): 441
Lamarche, B.; Mauriege, P.; Cantin, B.; Lupien, P.J.; Dagenais, G.R.; Despres, J.P.erre 1999: Plasma free fatty acid concentrations and the risk of ischemic heart disease in men Prospective results from the Quebec Cardiovascular Study. Diabetes 48(Suppl 1): A171
Ambler, C.; Mao, C.S.; Berman, N.; Ipp, E. 1999: Plasma free fatty acid oscillations in healthy, obese, and type 2 diabetic subjects. Journal of Investigative Medicine 47(2): 76A
Lemieux, S.; Weisnagel, S.J.; Piche, M.E.; Bergeron, J.; Nadeau, A. 2002: Plasma free fatty acid suppression in response to hyperinsulinemia in postmenopausal women. International Journal of Obesity 26(Suppl 1): S78
Kim, J.Y.; Zheng, D.; Berggren, J.R.; Dohm, G.L.; Hulver, M.W. 2004: Plasma free fatty acids modulate skeletal muscle fatty acid oxidation via altered beta -hydroxy acyl-CoA dehydrogenase activity. FASEB Journal 18(4-5): Abstract 454
Dick, D.P.ula, I.; Dos Santos, J.E.; Foss, M.C.; Kettelhut, I.C.; Migliorini, R.H. 2000: Plasma free fatty acids turnover rate in obese and nonobese humans. International Journal of Obesity 24(Suppl 1): S136
Lenders, J.; Pacak, K.; Friberg, P.; Walther, M.; Keiser, H.; Eisenhofer, G. 2000: Plasma free metanephrines A promising new neurochemical test for pheochromocytoma. Journal of Hypertension 18(Suppl 4): S34
Wu, X.W.; Li, Q.Z.; Lian, E.C. 1999: Plasma from a patient with thrombotic thrombocytopenic purpura induces endothelial cell apoptosis and platelet aggregation. Thrombosis Research 93(2): 79-87
Orth, T.A.; Allen, J.A.; Wood, J.G.; Gonzalez, N.C. 2004: Plasma from hypoxic rats increases leukocyte-endothelial adherence in normoxic cremaster rat venules. FASEB Journal 18(4-5): Abstract 845
Contaretti, S.; Noris, M.; Benigni, A.; Remuzzi, G.; Galbusera, M. 2001: Plasma from patients with HUS and TTP proteolyzes vWF subunit independently from the presence of absence of the Ba2+-dependent-cleaving protease activity. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 98A
Jimenez, J.J.; Jy, W.; Mauro, L.M.; Ahn, E.R.; Horstman, L.L.; Ahn, Y.S. 2003: Plasma from patients with ITP-associated dementia activates endothelial cells and enhances transendothelial migration of leukocytes. Blood 102(11): 294a
Coward, R.J.; Ni, L.; Mathieson, P.W.; Saleem, M.A. 2001: Plasma from patients with focal segmental glomerulosclerosis affects the podocyte cytoskeleton and cell differentiation. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 675A
Bjornsen, A.J.; Voelkel, N.F.; Silliman, C.C. 2000: Plasma from stored apheresis and whole blood derived platelet concentrates causes lung injury in an animal model of TRALI. FASEB Journal 14(4): A607
Silliman, C.; Elzi, D.; Hiester, A. 1999: Plasma from stored blood activates pulmonary endothelial cells. Journal of Investigative Medicine 47(4): 209A
Silliman, C.C.; Elzi, D.J.; Voelkel, N.F. 1999: Plasma from stored but not fresh whole blood platelets causes acute lung injury in an animal model of TRALI. Transfusion 39(10 Suppl): 2S-3S
Gutierrez, B.L.; Rosso, P.; Salas, S.P. 2001: Plasma from women with idiopathic fetal growth restriction contains a factor that alters endothelial cell function. Hypertension 37(3): 1014
Kawasaki, T.; Ogata, N.; Akanuma, H.; Yomanouchi, T. 2003: Plasma fructose significantly increased after the oral glucose loading in patients with type 2 diabetes. Diabetes 52(Suppl 1): A549
Fan, J.; Dwyer, K.M.; Shircore, A.M.; Dwyer, J.H. 2002: Plasma g-tocopherol and early atherosclerosis The Los Angeles atherosclerosis study. American Journal of Epidemiology 155(11 Suppl): S67
Zhao, Zeng Li 2003: Plasma gasification of biomass in a downflow reactor. Abstracts of Papers American Chemical Society 226(1-2): FUEL 48
Gasiorowska, A.; Orszulak Michalak, D.; Bombski, G.; Kotynia, J.; Strzelczyk, J.; Janiak, A.; Malecka Panas, E.I. 2002: Plasma gastrin, CEA and CA 19-9 concentrations differ in patients with proximal and distal colorectal cancer. Gastroenterology 122(4 Suppl 1): A 592
Kornaszewska, A.; Urbaniak, J.; Wozniak, M.; Nowicka, J. 2001: Plasma gelatinase activity and PMN elastase concentration in patients with acute myelogenous leukemia and chronic myelogenous leukemia. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S272
Milewicz, A.A.; Bednarek Tupikowska, G.; Jedrzejuk, D. 2002: Plasma ghrelin and resistin in hysterectomized women after transdermal estradiol treatment. International Journal of Obesity 26(Suppl 1): S204
Hanusch Enserer, U.; Cauza, E.; Dunky, A.; Tura, A.; Pacini, G.; Rosen, H.R.; Brabant, G.; Prager, R.; Roden, M. 2003: Plasma ghrelin concentration is not correlated with insulin resistance but increased after severe weight loss in morbid obesity following laparoscopical gastric banding. Diabetes and Metabolism 29(Hors serie 2): 4S154
Hanusch Enserer, U.; Cauza, E.; Brabant, G.; Rosen, H.R.; Pacini, G.; Dunky, A.; Prager, R.; Roden, M. 2003: Plasma ghrelin in morbid obesity before and after weight loss following laparoscopical adjustable gastric banding. International Journal of Obesity 27(Suppl 1): S50
Jedrzejuk, D.; Milewicz, A.; Arkowska, A.; Lwow, F. 2002: Plasma ghrelin levels in obese postmenopausal women after Orlistat treatment. International Journal of Obesity 26(Suppl 1): S155
Sasaki, M.; Myojo, S.; Tsujikawa, T.; Fujiyama, Y.; Bamba, T.; Sato, T.; Sasaki, K. 1999: Plasma glicentin, an active enteroglucagon, concentration in patients with Crohns disease. Journal of Parenteral and Enteral Nutrition 23(5 Suppl): S162
Browning, R.Jr; Myles, Y.G.; Payton, T.L. 2002: Plasma glucagon, IGF-1 and metabolite concentrations in Hereford and Senepol steers on orchardgrass or endophyte-infected tall fescue. Journal of Dairy Science 85(Suppl 1): 68
Handasyde, K.A.; Mcdonald, I.R.; Evans, B.K. 2003: Plasma glucocorticoid concentrations in free-ranging platypuses Response to capture and patterns in relation to reproduction. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 136A(4): 895-902
Manco, M.; Mingrone, G.; Parigi, Del; De Gaetano, A.; Capristo, E.; Greco, A.V. 2001: Plasma glucose disappearance rate and restoration of euglycemia are not affected by repeated insulin-induced hypoglycemia in normal volunteers. Diabetologia 44(Suppl 1): A219
Bonora, E.; Kiechl, S.; Willeit, J.; Oberhollenzer, F.; Egger, G.; Bonadonna, R.; Muggeo, M. 1999: Plasma glucose in the normal range is not associated with carotid atherosclerosis A longitudinal population-based study. Diabetes 48(Suppl 1): A173
Garg, S.K.; Chase, H.P.; Marshall, G. 2001: Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin. Diabetes 50(Suppl 2): A435-A436
S.L.wrence, A.C.; Lawrence, L.M.; Hayes, S.H.; Adams, M. 2001: Plasma glucose responses of growing horses to different concentrate feeds. Journal of Dairy Science 84(Suppl 1): 208-209
Griffin, J.H.; Deguchi, H.; Fernandez, J. 2004: Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)
Huijmans, J.G.M.; De Klerk, J.B.C.; Jankie, R.; Williams, M.; Duran, M. 2000: Plasma glutamine/glutamate, associated with hyperammonemia of various origin. Journal of Inherited Metabolic Disease 23(Suppl 1): 49
Ashfaq, S.; Beinart, S.C.; Abramson, J.L.; Rhodes, S.D.; Jurkovitz, C.; Vaccarino, V.; Williams, J.K.; Jones, D.P.; Quyyumi, A.A.; Weintraub, W.S.; Harrison, D.G. 2003: Plasma glutathione redox state A novel marker of oxidative stress, correlates with early atherosclerosis in humans. Journal of the American College of Cardiology 41(6 Suppl A): 293A-294A
Gupta, A.; Rosen, M.R.; Rosen, T.S. 2002: Plasma gonadal steroids influence the neonatal electrocardiographic QT interval. Pediatric Research 51(4 Part 2): 387A
Popova, V.V.; Mankovsky, B.N. 1999: Plasma growth hormone levels in patients with newly diagnosed insulin-dependent diabetes. Diabetologia 42(Suppl 1): A202
Dueker, S.R.; Follett, J.R.; Lin, Y.; Buchholz, B.; Vogel, J.S.; Clifford, A.J. 2001: Plasma half-lives of beta-carotene following IV infusion of autologous 14C-carotene-labeled plasma in humans. FASEB Journal 15(5): A953
Gymnich, S.; Petersen, B.; Bidlingmaier, M.; Wimmers, K.; Schellander, K. 2002: Plasma haptoglobin concentration in 30 kg and 80 kg pigs after three hours transport. Tieraerztliche Umschau 57(12): 673-676, 1 Dezember
Gunther, R.; Driessen, B.; Lurie, F.; Jahr, J. 2003: Plasma hemoglobin contribution to oxygen consumption by a hemoglobin-based oxygen carriers in a canine hypovolemia model. FASEB Journal 17(4-5): Abstract 806
Deguzman, L.J.; Nieto, J.M.; Deguzman, S.A.; Conrad, A.; Collins, B. 2001: Plasma hepatitis C virus RNA is comparable to hepatic HCV RNA when obtained while on therapy at the end of treatment as a predictor of sustained response in patients with chronic hepatitis C infection. Gastroenterology 120(5 Suppl 1): A 30
De Vecchi, A.F.; Bamonti, F.; Finazzi, S.; De Franceschi, M.; Colucci, P.; Naggi, P.; Novembrino, C.; Valenti, G.; Ponticelli, C. 1999: Plasma homocystein levels in dialysis patients. Nephrology Dialysis Transplantation 14(9): A236
Bukhari, S.A.; Rajoka, M.I.; Nagra, S.A.; Rehman, Z.U. 2010: Plasma homocysteine and DNA damage profiles in normal and obese subjects in the Pakistani population. Molecular Biology Reports 37(1): 289-295
Cerone, R.; Piana, A.; Verrastro, G.; Minniti, G.; Mocchi, M.; Zanardi, S.; Perroni, L.; Cardillo Piccolino, F.; Armani, U. 2002: Plasma homocysteine and MTHFR genotype in patients with retinal vein occlusion. Journal of Inherited Metabolic Disease 25(Suppl 1): 37
Kark, J.D.; Selhub, J.; Bostom, A.; Adler, B.; Rosenberg, I.H. 1999: Plasma homocysteine and all-cause mortality in diabetes. Lancet 353(9168): 1936-1937
Martinez Berriotxoa, A.; Aguirre, C.; Egurbide, M.V.; Pijoan, J.I.; Rueda, M. 2001: Plasma homocysteine and arterial atherothrombotic disease in SLE patients. Lupus 10(Suppl 1): S27
Mbewu, A.D.; Nogoduka, C.; Taylor, B. 2003: Plasma homocysteine and arterial thromboembolic disease. South African Medical Journal 93(3): 192-194
Lovric, M.; Zrinski Topic, R.; Skodlar, J.; Maradin, M.; Stavljenic Rukavina, A. 1999: Plasma homocysteine and blood lipids in patients with coronary atherosclerosis. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S450
Mcneal, M.G.; Moore, M.; Zitzelberger, T.A.; Siemsen, G.; Oken, B.; Kaye, J.A. 2003: Plasma homocysteine and brain volume in healthy oldest old. Neurology 60(5 Suppl 1): A114
Hermans, M.P.; Jamart, J.; Dranais, A.S.; Wallemacq, P.; Buysschaert, M. 2001: Plasma homocysteine and chronic complications in type 1 diabetes. Diabetologia 44(Suppl 1): A308
Drzewoski, J.; Czupryniak, L.; Bald, E. 2000: Plasma homocysteine and circadian blood pressure variation in type 2 diabetes mellitus patients. Diabetologia 43(Suppl 1): A265
Chambers, J.C.; Anand, I.S.; Wander, G.S.; Kooner, J.S. 2002: Plasma homocysteine and coronary heart disease mortality in India. Circulation 106(19): 2; 732-II 733
Dramais, A.S.; Hermans, M.P.; Wallemacq, P.E.; Vandeleene, B.; Buysschaert, M. 1999: Plasma homocysteine and degree of insulin resistance in subjects with type 2 diabetes. Diabetologia 42(Suppl 1): A330
Idzior Walus, B.; Sieradzki, J.; Cyganek, K.; Fedak, D.; Kawalec, E. 2001: Plasma homocysteine and insulin sensitivity in women with gestational diabetes. Diabetes 50(Suppl 2): A384
Rasouli, M.L.; Budoff, M.J.; Park, R.; Aziz, D. 2002: Plasma homocysteine and not C-reactive protein predicts progression of atherosclerosis. Journal of the American College of Cardiology 39(5 Suppl A): 359A
Jones, G.; Leroux, C.; Jackson, D.; Stuttard, J.; Frost, G.; Alaghband Zadeh, J.; Laycock, J.F.; Reaveley, D. 2001: Plasma homocysteine and orlistat-induced weight loss in obesity. Clinical Science (London) 101(2): 9P
Salvayre, R.; Couderc, F.; Bayle, C.; Malatray, P.; Valdiguie, P.M.; Causse, E. 1999: Plasma homocysteine and other thiols determination by capillary electrophoresis and laser-induced fluorescence. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S460
Martinez, M.E.; Giuliano, A.R.; Marshall, J.R.; Kramer, C.B.; Alberts, D.S. 2001: Plasma homocysteine and recurrence of adenomatous polyps. Proceedings of the American Association for Cancer Research 42: 153
Pickrell, J.W.; Renlund, D.G.; Beddhu, S.; Allen, K.; Cheung, A.K.; Bair, T.L.; Anderson, J.L. 2001: Plasma homocysteine and renal insufficiency are independent and additive predictors of death/myocardial infarction in patients with angiographically-defined coronary disease. Circulation 104(17): 2; 393-II 394
D.C.terina, R.; Lazzerini, G.; Carluccio, M.; Vanuzzo, D.; Pilotto, L.; Fioretti, P.; Diviacco, S.; Gregori, D.; Quadrifoglio, F. 2001: Plasma homocysteine and soluble adhesion molecules as long-term predictors of cardiovascular events in a healthy population A nested case-control study. European Heart Journal 22(Abstract Suppl): 258
Martinez Berriotxoa, A.; Aguirre, C.; Alvarez, A.; Pijoan, J.I.; Rueda, M. 2001: Plasma homocysteine and venous thrombotic disease in SLE patients. Lupus 10(Suppl 1): S27
Candito, M.; Parrot, F.; Jacob, N.; Calaf, R.; Charpiot, P.; Sarthoui, M.; Garcon, D.; Van Obberghen, E.; Kamoun, P. 1999: Plasma homocysteine assays Comparison of liquid chromatography methods and the ABBOTT automated immunoassay. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S121
Bailey, L.B.; Duhaney, R.; Kauwell, G.P.A.; Maneval, D.; Hutson, A.; Davis, S.; Quinlivan, E.P.; Gregory, J.F. 2002: Plasma homocysteine association with vitamin B12 and folate status in young women with combined polymorphisms of the methylenetetrahydrofolate reductase gene. FASEB Journal 16(4): A268
Ciani, A.; Novembrino, C.; De Vecchi, A.F.; Bamonti Catena, F.; Valenti, G.; De Franceschi, M.; Fasano, M.A.; Buccianti, G.; Cavalca, V. 1999: Plasma homocysteine concentration in hemodialysis and peritoneal dialysis patients. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S90
Hoffman, J.; Reaveley, D.A.; Jackson, D.; Le Roux, C.; Alaghband Zadeh, J. 2001: Plasma homocysteine concentration in myxoedema. Clinical Science (London) 101(2): 10P
Siemianowicz, K.; Gminski, J.; Danch, A.; Magiera Molendowska, H.; Machalski, M. 2002: Plasma homocysteine concentration in patients with small cell and non-small cell lung cancer. International Journal of Molecular Medicine 10(Suppl 1): S97
Tormala, M.L.; Rantala, M.; Alfthan, G.; Aro, A.; Savolainen, M.J.; Kesaniemi, Y.A. 1999: Plasma homocysteine concentration is decreased by diet-induced change in serum folic acid level. Circulation 100(18): 1; 25
Dhindsa, S.; Aljada, A.; Ghanim, H.; Mohanty, P.; Bandyopadhyay, A.; Dandona, P. 2003: Plasma homocysteine concentrations are elevated in the obese and in males Absence of an effect by thiazolidinediones. Diabetes and Metabolism 29(Hors serie 2): 4S166
Podracka, L.; Rybarova, E.; Hrbkova, H.; Baltesova, T.; Gombos, V. 1999: Plasma homocysteine concentrations are not associated with lipoprotein levels in children with chronic renal failure. Nephrology Dialysis Transplantation 14(9): A133
Snehalatha, C.; Ramachandran, A.; Satyavani, K.; Sivasankari, S.; Viswanathan, V. 2000: Plasma homocysteine concentrations in CAD in Asian Indians. Diabetes Research and Clinical Practice 50(Suppl 1): S369-S370
Rodriguez, J.F.; Escobales, N.; Rodriguez, J.L.; Cruz, D.; Figueroa, Y.; Altieri, P.I. 1999: Plasma homocysteine concentrations in Hispanic patients with coronary heart disease. FASEB Journal 13(4 Part 1): A555
Dirisamer, A.; Lindemayr, A.; Widhalm, K. 2001: Plasma homocysteine concentrations in children of families with myocardial infarction before the age of 55 years. Pediatric Research 49(2): 295
Dirisamer, A.; Reiter, M.; Widhalm, K. 2004: Plasma homocysteine concentrations in children of families with proven myocardial infarction before the age of 55 years. Acta Paediatrica 93(4): 575-576
Knight, E.M.; Kessee, L.S.; Scholfield, D.; Habib, S.; Hallfrisch, J.; Bailey, U.J.; West, W.L. 2002: Plasma homocysteine concentrations in diabetic and non-diabetic African American subjects. FASEB Journal 16(4): A257
Apeland, T.; Mansoor, M.A.; Standjord, R.E.; Kristensen, O. 1999: Plasma homocysteine concentrations in patients with epilepsy on carbamazepine monotheraphy. Epilepsia 40(Suppl 2): 280
Yu, S.; Schultze, E.; Morris, J.G. 1999: Plasma homocysteine concentrations is affected by folated status and sex of cats. FASEB Journal 13(4 Part 1): A229
Idzior Walus, B.; Cyganek, K.; Stefko, K.; Seghieri, G.; Breschi, M.; Hebda Szydlo, A.; Kawalec, E.; Sieradzki, J. 2003: Plasma homocysteine correlates in women with gestational diabetes. Diabetologia 46(Suppl 2): A 249
Whisenant, B.; Muhlestein, J.B.; Lappe', D.L.; Carlquist, J.F.; Bair, T.L. 2002: Plasma homocysteine does not predict clinical restenosis after percutaneous coronary intervention. Circulation 106(19): II583
Martinez Berriotxoa, A.; Aguirre, C.; Egurbide, M.V.; Pijoan, J.I.; Rueda, M. 2001: Plasma homocysteine in SLE patients. Lupus 10(Suppl 1): S26
Matteucci, E.; Rossi, L.; Lucchetti, A.; Calvi, D.; Marchini, F.; Grandi, G.; Mariani, S.; Fagnani, F.; Boldrini, E.; Giampietro, O. 2000: Plasma homocysteine in families of type 1 diabetic patients. Journal of Endocrinological Investigation 23(6 Suppl): 46
Kamel, L.N.; Bibawi, H.; Essa, M.; Badawi, E. 2002: Plasma homocysteine in hemodialysis patients and chronic stable renal transplant recipients. Clinical Chemistry 48(6 Suppl): A90-A91
de Larrañaga, G.; Alonso, B.; Puga, L.; Benetucci, J. 2003: Plasma homocysteine in human immunodeficiency virus infected patient. Medicina 63(5): 393-398
Suliman, M.E.; Stenvinkel, P.; Heimburger, O.; Qureshi, A.R.; Barany, P.; Lindholm, B.; Bergstrom, J. 2000: Plasma homocysteine in predialysis patients is influenced by nutritional status and is lower in patients with than without cardiovascular disease. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 77A
Os, I.; Westheim, A.S.; Abdelnor, M.; Brekke, M. 2000: Plasma homocysteine in women with coronary artery disease and elevated blood glucose or diabetes mellitus is not affected by hormone replacement therapy. Diabetes Research and Clinical Practice 50(Suppl 1): S298
Gomez, P.; Blazquez, A.; Diaz Rubio, P.; Gomez Izquierdo, T.; Larumbe, S.; Fernandez Miranda, C. 2001: Plasma homocysteine increases in postmenopausal women. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S206
Hak, A.E.; Poldermann, K.H.; Stehouwer, C.D.A.; Westerndorp, I.C.D.; Hofman, A.; Witteman, J.C.M. 1999: Plasma homocysteine increases with menopause. Circulation 99(8): 1122
Schnyder, G.; Flammer, Y.; Roffi, M.; Pin, R.; Hess, O.M. 2001: Plasma homocysteine influences outcome after coronary angioplasty. European Heart Journal 22(Abstract Suppl): 121
Barrano, B.; Bertrand, G.; Isaja, T.; Curreri, R.; Musumeci, S. 2000: Plasma homocysteine is not involved in the thrombotic risk of beta-thalassemia major patients. Acta Haematologica 104(2-3): 148-150
Colhoun, H.; Rubens, M.; Underwood, S.R.; Ford, R.; Fuller, J.H. 2000: Plasma homocysteine is reduced in type 1 diabetes and is not associated with coronary calcification. European Heart Journal 21(Abstract Suppl): 629
Pniewski, J.ła.; Chodakowska-Zebrowska, M.łg.; Woźniak, R.ła.; Stepień, K.; Stafiej, A. 2003: Plasma homocysteine level and the course of ischemic stroke. Acta Neurobiologiae Experimentalis 63(2): 127-130
Jermendy, G.; Hidvegi, T.; Hetyesi, K. 2000: Plasma homocysteine level in hyperinsulinaemic subjects with different stages of glucose intolerance. Diabetologia 43(Suppl 1): A266
Makowiecka Ciesla, M.; Dzielinska, Z.; Kadziela, J.; Sitkiewicz, D.; Januszewicz, A.; Ruzyllo, W. 2000: Plasma homocysteine level in patients with essential hypertension. Journal of Hypertension 18(Suppl 4): S51
Barutcu, I.; Sezgin, A.; Ozdemir, R.; Gullu, H.; Topal, E. 2003: Plasma homocysteine level in slow coronary flow. European Heart Journal 24(Abstract Suppl): 635
Peltier, M.; Tribouilloy, C.M.; Iannetta Peltier, M.C.; Lesbre, J.P.ilippe M. 1999: Plasma homocysteine level is a powerful marker of the presence and severity of thoracic aortic atherosclerosis. Circulation 100(18): 1; 800
Cossu, M.; Carru, C.; Pes, G.M.; Satta, R.; Mura, A.; Errigo, A.; Sanna, S.; Naitana, A.; Deiana, L.; Sorba, G.; Pinna, G.G. 2001: Plasma homocysteine levels and C677T MTHFR gene polymorphism in stable renal graft recipients. Transplantation Proceedings 33(1-2): 1156-1158
Yoshitsugu, M.; Hisano, N.; Hiyoshi, T.; Akasu, F. 2000: Plasma homocysteine levels and atherosclerotic diseases in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 50(Suppl 1): S301
Grekas, D.; Makedou, A.; Theodoridou, A.; Avdelidou, A.; Kalevrosoglou, I.; Tourkantonis, A. 2000: Plasma homocysteine levels and the prevalence of atherosclerotic vascular disease in hemodialysis patients. Nephrology Dialysis Transplantation 15(9): A147
Olszewski, R.; Grabysa, R.; Warminski, J.; Makowski, T.; Szczechowicz, R.; Piechota, W.; Adamus, J. 2002: Plasma homocysteine levels and their reduction with folic acid/vitamin B6 in a cohort of apparently healthy young men in Polish population. European Heart Journal 23(Abstract Suppl): 190
Jovin, I.S.; Wolfe, M.L.; Gefter, W.B.; Miller, W.T.Jr.; Aronchick, J.M.; Flannery, D.T.; Shaw, L.; Mohler, E.R.IIi; Rader, D.J. 1999: Plasma homocysteine levels are not associated with extent of coronary artery calcification in asymptomatic persons. Circulation 100(18): 1; 25
Meigs, J.B.; Jacques, P.; Selhub, J.; Murphy Sheehy, P.; Nathan, D.; Singer, D.; D'agostino, R.; Wilson, P. 1999: Plasma homocysteine levels do not increase significantly across the spectrum of glucose tolerance The Framingham Offspring Study. Diabetes 48(Suppl 1): A165
Willcox, B.J.; Suzuki, M.; Willcox, D.C.; Todoriki, H.; Akisaka, M.; Hensrud, D.D. 2000: Plasma homocysteine levels in Japanese men and women. Journal of Investigative Medicine 48(2): 205A
Sassi, S.; Cosmi, B.; Palareti, G.; Legnani, C.; Grossi, G.; Coccheri, S. 1999: Plasma homocysteine levels in a cohort of apparently healthy subjects in Northern Italy Relation to age, sex and nutritional status. European Heart Journal 20(ABSTR Suppl ): 667
Filipovsky, J.; Svobodova, V.; Zarybnicka, M.; Ticha, M.; Pecen, L.; Stehlik, P. 2000: Plasma homocysteine levels in elderly hypertensive patients. Journal of Hypertension 18(Suppl 4): S45
Zarybnicka, M.; Filipovsky, J.; Svobodova, V.; Pecen, L.; Stehlik, P. 2000: Plasma homocysteine levels in elderly hypertensive subjects and healthy controls. Hypertension 36(4): 669
Tobe, S.W.; Naimark, D.N.J.; Helmers, K.F.; Perkins, N.J.; Baker, B. 1999: Plasma homocysteine levels in patients on chronic haemodialysis are inversely correlated with folate and B12 levels. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 306A
Gomez, P.; Fernandez Miranda, C.; Aranda, J.L.; Diaz Rubio, P.; Estenoz, J. 1999: Plasma homocysteine levels in patients with coronary disease. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S334
Ormen, M.; Tuncel, P.; Ozturk, V.; Ozkan, E.; Kutluk, K.; Onvural, B. 2001: Plasma homocysteine levels in stroke patients with different infarct areas. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S222
Keles, M.; Unlu, Y.; Becit, N.; Kocogullari, C.U.; Kocak, H.; Bakan, E. 2002: Plasma homocysteine levels in subjects with deep-vein thrombosis. Clinical Chemistry 48(6 Suppl): A101
Ferreira, C.; Fiuza, T.; Freire, I.; Barreto, M.; Crespo, F.; Vicente, A. 2001: Plasma homocysteine levels in systemic lupus erythematosus patients and their healthy consanguineous relatives. Lupus 10(Suppl 1): S120
Alrashed, M.M.; Erbil, M.; Almarafi, A.; Akgul, E.; Abugoush, M.; Bingol, N.; Kutluay, T. 2002: Plasma homocysteine levels in the Gulhane Military Medical Staff and searching myocard infarction risk. Clinical Chemistry 48(6 Suppl): A85
Sipahi, E.; Nadirler, F.; Taskin, G.; Yildirimkaya, M.; Laleli, Y. 1999: Plasma homocysteine levels in the Turkish population. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S458
Diakoumopoulou, E.; Kirlaki, E.; Tentolouris, N.; Perea, D.; Kitsou, E.; Ioannidis, I.; Sereti, E.; Tsapogas, P.; Alevizou, V.; Katsilambros, N. 2002: Plasma homocysteine levels in type 2 diabetic patients in relation to different risk factors for macroangiopathy. Diabetologia 45(Suppl 2): A 271
Cassone Faldetta, M.; De Luca, O.; Fava, D.; Proietti, A.; Bravi, M.C.; Ferri, C.; De Mattia, G. 2000: Plasma homocysteine levels in type 2 normotensive and hypertensive diabetic patients. American Journal of Hypertension 13(4 Part 2): 94A
Tricoci, P.; Melloni, C.; Melandri, G.; Branzi, A. 2003: Plasma homocysteine levels independently correlate with angiographic extension of coronary artery disease. European Heart Journal 24(Abstract Suppl): 436
Reyes Engel, A.; Morel, M.; Aranda, F.J.; Munoz Moran, E.; Aranda, P.; Ruiz, M.; Munoz, P.; Dieguez, J.L.; Fernandez Arcas, N. 2002: Plasma homocysteine levels, C677T polymorphism of the methylene-tetrahydrofolate reductase gene, plasma renin activity and cardiovascular risk. American Journal of Hypertension 15(4 Part 2): 154A
Pernet, P.; Cuzon, G.; Lim, S.K.; Vaubourdolle, M. 2004: Plasma homocysteine measurement with ion-exchange chromatography A comparison with the Abbott IMx assay. Clinical Chemistry 50(6, Suppl S, Part 2): A60
Duell, P.B.; Malinow, M.R.; O'malley, J.P.; Connor, W.E.; Illingworth, D.R. 2000: Plasma homocysteine modulates risk for coronary artery disease in patients with familial hypercholesterolemia. Journal of Investigative Medicine 48(2): 187A
Lopez, J.B.; Peng, C.Lai. 2004: Plasma homocysteine reference values of adult Malaysians from three ethnic groups. Clinica Chimica Acta; International Journal of Clinical Chemistry 340(1-2): 235-238
Castro, R.; Struys, E.A.; Jansen, E.E.W.; Rivera, I.; Blom, H.J.; Jakobs, C.; Camilo, M.E.; Tavares, D.A.meida, I. 2002: Plasma homocysteine, SAM/SAH ratio and global DNA methylation status in premature vascular disease. Journal of Inherited Metabolic Disease 25(Suppl 1): 36
Casas, J.P.; Bautista, L.E.; Hingorani, A.D.; Sharma, P. 2004: Plasma homocysteine, and ischaemic stroke Mendelian randomization provides further evidence of causal link. Journal of Neurology Neurosurgery and Psychiatry 75(8): 1218
Nilsson, K.; Gustafson, L.; Nornholm, M.; Hultberg, B.ör. 2010: Plasma homocysteine, apolipoprotein e status and vascular disease in elderly patients with mental illness. Clinical Chemistry and Laboratory Medicine 48(1): 129-135
Araki, A.; Sako, Y.; Ito, H.; Orimo, H. 1999: Plasma homocysteine, brain MR lesions, and cognitive functions in elderly diabetic patients. Amino Acids 17(1): 44
Trimarchi, H.; Schiel, A.; Schropp, J.; Almeida, C.; Pereyra, H.; Freixas, E.; Diaz, M.L. 2000: Plasma homocysteine, folic acid, vitamin B12, albumin and hematocrit levels in ESRD patients on chronic hemodialysis before and after treatment with IV mecobalamin and/or oral folic acid supplementation. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 303A
Idzior Walus, B.; Cyganek, K.; Fedak, D.; Sieradzki, J. 2000: Plasma homocysteine, lipids and insulin concentrations in women with gestational diabetes. Diabetologia 43(Suppl 1): A217
Kelemen, L.; Anand, S.; Hegele, R.; Stampfer, M.; Rosner, B.; Willett, W.; Lonn, E.; Montague, P.; Vuksan, V.; Teo, K.; Devanesen, S.; Yusuf, S. 2004: Plasma homocysteine, the methylenetetrahydrofolate reductase C677T polymorphism and intima media thickness among South Asian, Chinese and European Canadians. American Journal of Epidemiology 159(11, Suppl S): S105
Holman, R.; Stratton, I.; Johnston, C.; Clarke, R. 2001: Plasma homocysteine, type 2 diabetes and risk of coronary heart disease in the UKPDS. Circulation 104(17): 2; 3
Panas, M.; Markianos, M.; Kalfakis, N.; Vassilopoulos, D. 2003: Plasma homovanillic acid in Huntingtons disease Relation to the severity of the illness. European Journal of Neurology 10(Suppl 1): 192
Li, W.; Scarlly, D.; Kemp, M.; Hooper, J.; Gatzoulis, M.; Gibson, D.G. 2001: Plasma hormonal and renal water-electrolyte excretion responses to water loading in patients with one ventricle heart Influence of type of surgery. European Heart Journal 22(Abstract Suppl): 81
Mugaas, J.N. 1999: Plasma hormone concentrations show daily and seasonal variation in the Virginia opossum, Didelphis virginiana. FASEB Journal 13(5 Part 2): A739
Graham Thiers, P.M.; Kronfeld, D.S.; Harris, P.A. 2002: Plasma hydrogen ion and bicarbonate changes during repeated sprints in horses are influenced by dietary protein. Journal of Dairy Science 85(Suppl 1): 172
Munoz Blanco, J.L.; Anaya, F.; Rodriguez Mahou, M.; Gimenez Roldan, S. 1999: Plasma immunoadsorption in myasthenia gravis. Neurology 52(6 Suppl 2): A156
Abdel Sayed, S.; Gohlke, P.; Brunner, H.R.; Nussberger, J. 2003: Plasma immunoreactive endothelin-1 levels in hypertensive rats and human subjects. American Journal of Hypertension 16(5 Part 2): 24A
Wechsel, H.W.; Feil, G.; Bichler, K.H.; Gleichmann, R. 1999: Plasma inactive form pyruvate kinase in renal cell carcinoma An acceptable marker?. Anticancer Research 19(6D): 5724
Odonovan, D.J.; Fernandes, C.J.; Nguyen, N.Y.; Adams, K.; Adams, J.M. 2003: Plasma indomethacin level monitoring and patent ductus arteriosus closure rates in premature infants. Pediatric Research 53(4 Part 2): 499A
Crofton, P.; Evans, A.E.M.; Groome, N.; Kelnar, C.J.H. 2000: Plasma inhibin in boys during childhood and puberty Relationship with FSH and testosterone. Hormone Research 53(Suppl 2): 80
Crofton, P.M.; Evans, A.E.M.; Groome, N.; Kelnar, C.J.H. 2000: Plasma inhibin in healthy girls and in girls with disorders of puberty. Hormone Research 53(Suppl 2): 80
Gaggiotti, G.; Ricciotti, R.; Catani, M.; Ambrosi, S.; Saba, V. 1999: Plasma insulin and leptin levels in patients affected by severe obesity Effects of the body weight loss. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S335
Anichini, R.; De Bellis, A.; Malagoli, R.; Breschi, M.C.; Alviggi, L.; Seghieri, G. 2000: Plasma insulin concentration after a standardised oral glucose load is independently related to pregestational obesity in non diabetic pregnant women. Diabetologia 43(Suppl 1): A212
Masuo, K.; Mikami, H.; Ogihara, T.; Tuck, M. 2000: Plasma insulin level modulates plasma leptin level, but does not BP leve in diabetes. Journal of Hypertension 18(Suppl 4): S134
Van Loon, L.J.C.; Saris, W.H.M.; Verhagen, H.; Wagenmakers, A.J.M. 2000: Plasma insulin responses following the ingestion of various amino acid/protein-carbohydrate mixtures. FASEB Journal 14(4): A91
Tomasik, P.; Sztefko, K.; Szafran, Z.; Dziatkowiak, H. 1999: Plasma insulin, glucagon and pancreatic polypeptide levels in children with eating disorders. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S197
Giovannucci, E.; Pollak, M.N.; Platz, E.A.; Willett, W.C.; Stampfer, M.J.; Majeed, N.; Colditz, G.A.; Speizer, F.E.; Hankinson, S.S. 1999: Plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal cancer and adenoma in women. Proceedings of the American Association for Cancer Research 40: 211
Ballinger, A.B.; Azooz, O.G. 2001: Plasma insulin-like growth factor-1 concentrations are increased in adult IBD patients A risk factor for colorectal cancer?. Gastroenterology 120(5 Suppl 1): A 447
Vadgama, J.V.; Wu, Y.; Datta, G.; Khan, H.; Chillar, R. 1999: Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can by associated with progression of breast cancer, predict risk of recurrence and survival probability in African American and Hispanic women. Proceedings of the American Association for Cancer Research 40: 204
Byrne, C.; Colditz, G.A.; Pollak, M.; Willett, W.C.; Speizer, F.E.; Hankinson, S.E. 2000: Plasma insulin-like growth factor-I, insulin-like growth factor binding protein-3 and mammographic density. Proceedings of the American Association for Cancer Research 41: 222
Evans, C.; Robertson, S.; Gracie, A.; Mcinnes, I.; Morris, J. 2002: Plasma interleukin-18 levels in chronic alcoholic liver disease and alcoholic hepatitis are related to disease severity. Hepatology 36(4 Part 2): 727A
Pai, M.F.; Chiang, C.K.; Hsu, S.P.; Peng, Y.S.; Ho, T.I.; Hung, K.Y.; Tsai, T.J. 2003: Plasma interleukin-18 levels induced by hemodialysis procedure. Journal of the American Society of Nephrology 14(Abstracts Issue): 847A
Phelps, C.P.; Dong, J.M.; Chen, L.T.; Menzies, R.A. 2001: Plasma interleukin-1beta, prolactin, ACTH and corticosterone responses to endotoxin after damage of the anterior hypothalamic area. Neuroimmunomodulation 9(6): 340-351
Oristrell, J.; Sampere, M.; Amengual, M.J.; Font, B.; Segura, F. 2004: Plasma interleukin-6 levels in Mediterranean spotted fever. European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 23(5): 417-418
Benevenga, N.J.; Pope, L.L.; Crenshaw, T.D. 2001: Plasma iron, latent and total iron binding capacity and percent saturation of newborn and seven day old pigs. Journal of Animal Science 79(Suppl 2): 69
Walter, M.F.; Levin, N.W.; Nightingale, Z.D.; Handelman, G.J. 1999: Plasma isoprostanes markers of oxidative stress in patients of long term hemodialysis. FASEB Journal 13(4 Part 1): A564
Santos, R.; Oliveira, A.A.; Maranhao, R.C. 2000: Plasma kinetics of a emulsion that binds to LDL receptors in patients with coronary artery disease. European Heart Journal 21(Abstract Suppl): 628
Suslov, N. 2002: Plasma knife. Official Gazette of the United States Patent and Trademark Office Patents 1262(1)
Vianen, G.J.; Van Den Thillart, G.E.E.J.M.; Van Kampen, M.; Van Heel, T.I.; Steffens, A.B. 2001: Plasma lactate and stress hormones in common carp and rainbow trout during stepwise decreasing oxygen levels. Netherlands Journal of Zoology 51(1): 33-50
Kamijo, Y.; Takeno, Y.; Sakai, A.; Inaki, M.; Okumoto, T.; Itoh, J.; Masuki, S.; Yanagidaira, Y.; Nose, H. 2000: Plasma lactate concentration and muscle blood flow during dynamic exercise with continuous negative pressure breathing. FASEB Journal 14(4): A325
Raho, V.J.; Zell, S.C. 2001: Plasma lactate levels in HIV patients on long-term Nucleoside Analogue therapy A comparison to existing reference norms. Journal of Investigative Medicine 49(1): 49A
Myburgh, K.H.; De Pao, A.; Kohn, T. 2001: Plasma lactates after 5 km time trials remain elevated and correlate with % slow twitch fibres. Medicine and Science in Sports and Exercise 33(5 Suppl): S341
Feigenbaum, A.; Wu, P. 2001: Plasma lactic acid levels in mitochondrial disease A good diagnostic or monitoring marker?. Mitochondrion 1(1): 96
Blanco, G.D.l Vecchio; Burroughs, A.K.; Owen, J.S. 1999: Plasma lecithin-cholesterol acyltransferase to monitor restoration of hepatocyte synthetic function following orthotopic liver transplantation. Journal of Hepatology 30(Suppl 1): 173
Prasad, U.K.; Carter, A.; Freeman, M.; Grant, P.J. 2003: Plasma leptin Associations with haemostatic cardiovascular risk factors and the metabolic syndrome in a family Study. Circulation 108(17): IV733
Krommidas, G.; Kostikas, K.; Papatheodorou, G.; Koutsokera, A.; Gourgoulianis, K.I.; Roussos, C.; Koulouris, N.G.; Loukides, S. 2010: Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers. Respiratory Medicine 104(1): 40-46
Kokot, F.; Lysiak Szydlowska, W.; Adamczak, M.; Rutkowski, B.; Chudek, J.; Ignacy, W.; Wiecek, A. 2000: Plasma leptin and carnitine concentration in haemodialyzed uraemic patients. Nephrology Dialysis Transplantation 15(9): A19
Chu N.F.; Shen M.H.; Wu D.M. 2003: Plasma leptin and insulin levels on 5 years body weight and BMI changes among school children in Taiwan The Taipei Children Heart Study. International Journal of Obesity 27(Suppl 1): S45
Robaczyk, M.G. 2002: Plasma leptin and its relationship to other body fat regulating hormones under constraints of endogenous cortisol levels. Roczniki Pomorskiej Akademii Medycznej w Szczecinie 48: 283-300
Turner, L.R.; Premo, D.; Chew, H.G. 2003: Plasma leptin and regional differences in arterial morphology with iron deficiency. FASEB Journal 17(4-5): Abstract 810
Freshwatera, D.A.; Al Dulaimi, D.; O'hare, P.; Randeva, H.; Nwokolo, C.U. 2002: Plasma leptin before and after cure of Helicobacter pylori. Gut 50(Suppl 2): A54
Huszenicza, G.; Kulcsar, M.; Nikolic, A.J.; Schmidt, J.; Korodi, P.; Katay, L.; Dieleman, J.S.; Rudas, P. 2000: Plasma leptin concentration and its interrelation with some blood metabolites, metabolic hormones and the resumption of cyclic ovarian function in postpartum dairy cows supplemented with Monensin or inert fat in feed. Reproduction in Domestic Animals (Suppl 6): 51-52
Sztefko, K.; Sztefko, K.; Kosowski, K.; Zajac, A.; Popiela, T.; Szafran, Z. 2000: Plasma leptin concentration depends on the billiary levels of the individual bile acids. Regulatory Peptides 94(1-3): 55, 25 October
Grekas, D.; Karamouzis, M.; Kalevrosoglou, I.; Kampouris, H.; Vassiliou, S.; Tourkantonis, A. 1999: Plasma leptin concentration in hemodialysis patients. Nephrology Dialysis Transplantation 14(9): A197
Howard, J.K.; Lord, G.M.; Mitra, S.; Baker, R.J.; Greenwood, R.N.; Lechler, R.I.; Bloom, S.R. 1999: Plasma leptin concentrations are reduced by high flux haemodialysis. Journal of Endocrinology 160(Suppl ): P43
Mann, G.E.; Fray, M.D.; Blache, D. 2002: Plasma leptin concentrations during early pregnancy in the dairy cow. Journal of Dairy Science 85(Suppl 1): 67
Appleton, D.J.; Rand, J.S.; Sunvold, G.D. 2000: Plasma leptin concentrations in cats before and after becoming obese, and the relationship between plasma leptin, adipositiy and insulin. Journal of Veterinary Internal Medicine 14(3): 377
Zavaroni, I.; Gasparini, P.; Barilli, A.L.; Massironi, P.; Zuccarelli, A.; Delsignore, R.; Reaven, G.M. 1999: Plasma leptin concentrations in insulin resistant as compared to insulin sensitive healthy volunteers. Diabetologia 42(Suppl 1): A192
Randall Simpson, J.; Paes, B.; Thompson, P.; Sadacharan, P.; Atkinson, S. 2001: Plasma leptin correlates with body fat in term-born and pre-term infants in the first year of life. Pediatric Research 49(4 Part 2): 411A
Prasad, U.; Carter, A.M.; Freeman, M.; Grant, P.J. 2003: Plasma leptin in a family study Associations with the metabolic syndrome and haemostatic cardiovascular risk factors. European Heart Journal 24(Abstract Suppl): 133
Sass, J.O.; Skladal, D. 2000: Plasma leptin in prepubertal patients with glycogen storage diseases. Hormone and Metabolic Research 32(1): 44-46
Manno, C.; Pertosa, G.; Corciulo, R.; Montinaro, V.; Schiavone, R.; Vaira, A.; Schena, F.P. 1999: Plasma leptin is increased in hemodialysis patients independently of malnutrition. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 292A
Geloneze, S.R.; Geloneze, B.; Repetto, E.M.; Picolo, M.; Pereira, S.G.; Tambascia, M.A. 2002: Plasma leptin is not associated with insulin resistance and metabolic syndrome components in a population-based study. International Journal of Obesity 26(Suppl 1): S7
Ohta, S.; Minami, J.; Yoshii, M.; Suzuki, T.; Ishimitsu, T.; Ohrui, M.; Matsuoka, H. 2000: Plasma leptin level correlates with serum lipid levels in men and insulin resistance in women. Journal of Hypertension 18(Suppl 4): S145
Matsuo, K.; Mikami, H.; Ogihara, T.; Tuck, M.L. 2000: Plasma leptin level does not play an important role on BP regulatory mechanisms in diabetes. American Journal of Hypertension 13(4 Part 2): 81A
Wolk, R.; Berger, P.; Lennon, R.J.; Brilakis, E.S.; Johnson, B.D.; Somers, V.K. 2004: Plasma leptin level is an important and independent predictor of prognosis in patients with established coronary atherosclerosis. Journal of the American College of Cardiology 43(5 Suppl A): 535A
Erturk, S.; Nergizoglu, G.; Kutlay, S.; Keven, K.; Ates, K.; Duman, N.; Ertug, A.E.gun 2000: Plasma leptin levels and response to erytropoietin in haemodialysis patients. Nephrology Dialysis Transplantation 15(9): A161
Wasikowa, R.; Iwanicka, Z.; Bergman, P.; Zak, T. 1999: Plasma leptin levels and selected metabolic parameters in obese children. Hormone Research 51(Suppl 2): 127
Canatan, H.; Bakan, I.; Akbulut, M.; Halifeoglu, I.; Baydas, G. 2004: Plasma leptin levels are not affected by commonly used anti-hypertensive drugs in patients with essential hypertension. FASEB Journal 18(4-5): Abstract 648
Leyva, F.; Anker, S.D.; Poole Wilson, P.A.; Coats, A.J.S. 1999: Plasma leptin levels are related to fatigue in patients with chronic heart failure. Journal of the American College of Cardiology 33(2 Suppl A): 194A
Torres, A.; Gomez, M.A.; Gonzalez, A.; Rufino, M.; Garcia, S.; Hernandez, D.; Lorenzo, V. 1999: Plasma leptin levels as a predictor of body fat and energy intake in stable long-term renal transplant patients. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 749A
Vega, M.J.; Vera, A.M.; Milena, A.; Rufino, M.; Zaera, A.; Gomez, M.A.; Gonzalez, A.; Torres, A.; Gonzalez, C.M. 1999: Plasma leptin levels as a predictor of body fat mass and energy intake in stable long-term renal transplant patients. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S511
Komorowski, J.; Jankiewicz Wika, J.; Stepien, H. 2000: Plasma leptin levels during Gn-RH, TRH and CRF tests in lean and obese women. International Journal of Obesity 24(Suppl 1): S143
Arancio, C.; Limonta, D.; Casolari, A.; Magni, P.; Motta, M.; Bellodi, L. 1999: Plasma leptin levels in anorexia nervosa. European Journal of Clinical Investigation 29(Suppl 1): 20
Sztefko, K.; Kosowski, K.; Malek, A.; Szafran, Z. 1999: Plasma leptin levels in cholecystectomized patients. Gastroenterology 116(4 Part 2): A37
Marti, A.; Ochoa, M.C.; Chueca, M.; Oyarzabal, M.; Pelach, R.; Azcona, C.; Martinez, D.L.zarrondo, S.; Rivero, A.; Martinez, J.A. 2003: Plasma leptin levels in obese children highly correlates with indices of insulin resistance. International Journal of Obesity 27(Suppl 1): S86
Simmons, L.; Turner, E.A.; Flakoll, P.J.; Buchowski, M.S. 1999: Plasma leptin levels in sickle cell disease Relationship to body fat, gender, age, and energy expenditure. FASEB Journal 13(5 Part 2): A1118
Yamaguchi, M.; Imoto, I.; Katsuki, A.; Sumida, Y.; Oka, S.; Toyoda, N.; Nakashima, S.; Taguchi, Y.; Adachi, Y. 2000: Plasma leptin levels increase after eradication of Helicobacter pylori in lean patients. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1327
Mendez Sanchez, N.; Gonzalez, V.; Suarez, J.A.; Sanchez, H.; Uribe, M. 1999: Plasma leptin levels modulates cholesterol secretion in obese patients losing weight. Gastroenterology 116(4 Part 2): A1245
Cinaz, P.; Bideci, A.; Ezgu, F.S. 2000: Plasma leptin levels of infants after feeding. Acta Paediatrica 89(6): 746
Chin Chance, C.; Polonsky, K.; Schoeller, D. 2000: Plasma leptin reflects energy balance. FASEB Journal 14(4): A262
Kirwan, J.P.; Del Aguila, L.F.; Sistrun, S.N.; White, A.D.; Treu, J.A.; Waara, J.H.; Kriz, D.A.; Krishnan, R.K.; White, R. 2000: Plasma leptin regulates resting energy expenditure but not satiety in obese men and women during weight loss. FASEB Journal 14(4): A433
Hickey, M.; Cooke, C.; Seebohar, R.; Franco, S.; Alvarez, G.; Curry, P.; Wagner, A. 2000: Plasma leptin responses to isocaloric and hypercaloric manipulations of dietary fat. Medicine and Science in Sports and Exercise 32(5 Suppl): S40
Castellanos, J.M.; Gimenez, C.; Lopez Teijon, M.L.; Olivares, R.; Moragas, M.; Verdu, N. 1999: Plasma leptin values after gonadotrophin stimulation. Human Reproduction 14(ABSTR BOOK 1): 180
Abdella, Nabila; Mojiminiyi, Olusegun; Moussa, Mohammed; Al Mohammedy, Hisham 2003: Plasma leptin, C-reactive protein and cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Diabetes 52(Suppl 1): A150
Volpe, L.; Di Cianni, G.; Casadidio, I.; Calabrese, M.; Maffei, M.; Ferdeghini, M.; Cecchetti, P.; Benzi, L. 2000: Plasma leptin, IGF-2 and IGFBP-3 levels in women with gestational diabetes mellitus. Journal of Endocrinological Investigation 23(6 Suppl): 46
Claudino, F.; Ferreira Dias, G.; Carvalho, H.; Agricola, R.; Robalo Silva, J. 2003: Plasma leptin, body weight and immune status on seasonal reproduction in mares. Reproduction in Domestic Animals 38(4): 328-329
Van Crevel, R.; Karyadi, E.; Netea, M.G.; Verhoef, H.; Nelwan, R.H.H.; West, C.E.; Van Der Meer, J.W.M. 2000: Plasma leptin, nutritional status, and the acute phase response in patients with tuberculosis. Immunobiology 203(1-2): 561-562
Holler, C.; Brath, H.; Nowotny, P.; Schreiber, B.; Zwick, H.; Irsigler, K. 2000: Plasma leptin-changes after nicotine application depend on the heart rate reaction. International Journal of Obesity 24(Suppl 1): S69
Liu, H.F.; Chen, X.W.; Xu, Y.Z.; Jing, L.M.; Wu, P.; Liu, H.Y. 2001: Plasma level and gene expression in PBMC of interleukin 18 in patients with primary glomerulonephritis. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 556A
Konturek, P.C.; Jaworek, J.; Bonior, J.; Maniatoglou, A.; Reh, H.; Schneider, T.; Konturek, S.J.; Hahn, E.G. 2001: Plasma level and pancreatic gene expression of leptin in acute pancreatitis in rats and in acute and chronic pancreatitis in humans. Gastroenterology 120(5 Suppl 1): A 726
Park, H.; Je, H.D.; Choi, D.S. 2000: Plasma level and redox status of vitamin C in diabetic rats. FASEB Journal 14(4): A492
Fujita, M.; Nanto, S.; Morozumi, T.; Watanabe, T.; Inoshiro, N.; Iwata, A.; Nagata, S. 2000: Plasma level of asymmetrical-dimethyl-arginine is increased in patients with type 2 diabetes mellitus Effects of ACE inhibitors. Circulation 102(18): 2; 62-II 63
Kosmala, W.; Spring, A. 2002: Plasma level of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension. European Heart Journal 23(Abstract Suppl): 457
Van Nieuwenhoven, F.; Roestenberg, P.; Wieten, L.; Boer, P.; Diekman, M.; Tiller, A.; Wiersinga, W.; Oliver, N.; Usinger, W.; Weitz, S.; Goldschmeding, R.; Schlingemann, R. 2002: Plasma level of connective tissue growth factor in diabetes mellitus correlates with albuminuria. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 689A
Mroczek Czernecka, D.; Kitlinski, M.; Nessler, J.; Stepniewski, M.; Piwowarska, W. 2003: Plasma level of endothelin-1 in patients with coronary artery disease. European Heart Journal 24(Abstract Suppl): 68
Yamamoto, Y.; Kohara, K.; Tabara, Y.; Ohnishi, M.; Ueki, S.; Yano, H.; Igase, M.; Nakura, J.; Miki, T. 2001: Plasma level of hepatocyte growth factor is associated with carotid intima-media thickness. American Journal of Hypertension 14(4 Part 2): 121A-122A
Nagai, Y.; Tasaki, H.; Kouzuma, R.; Tsutsui, M.; Okazaki, M.; Nakashima, Y. 2001: Plasma level of homocysteine is inversely associated with the development of collateral circulation. Journal of the American College of Cardiology 37(2 Suppl A): 307A
Thiel, S.; Peterslund, N.A.; Koch, C.; Jensenius, J.C. 2000: Plasma level of mannan-binding lectin as predictor of sepsis after chemotherapy. Immunopharmacology 49(1-2): 85
Matsumoto, T.; Minai, K.; Tarutani, Y.; Yasuda, Y.; Ohira, N.; Takashima, H.; Nakamura, Y.; Kinoshita, M. 2002: Plasma level of oxidized low density lipoprotein is an independent determinant of coronary macro- and microvascular endothelial function. Circulation 106(19): II277
Tomanoski, V.; Krpan, D. 2000: Plasma level of parathormone associated with an optimal bone histology in dialysis patients. Nephrology Dialysis Transplantation 15(9): A43
Onodera, H.; Fujihara, K.; Nakashima, I.; Itoyama, Y. 1999: Plasma level of plasminogen activator inhibitor-1 in patients with MS. Neurology 52(6 Suppl 2): A492
Meier, P.; Blanc, E. 2003: Plasma level of soluble Fas is an independent marker of cardiovascular disease in ESRD patients. Kidney International 64(4): 1532-1533
Moncrieff, J.; Lindsay, M.M.; Mcgavigan, A.D.; Maxwell, P.R.; Connell, J.M.C.; Dunn, F.G. 2001: Plasma level of tissue inhibitor of matrix metalloproteinase 1 reflects functional cardiovascular abnormalities in essential hypertension. Journal of the American College of Cardiology 37(2 Suppl A): 271A
Tomiyama, H.; Watanabe, G.; Kushiro, T.; Yoshida, H.; Namiki, T.; Ishikawa, Y.; Takahashi, A.; Doba, N. 2000: Plasma level of tissue plasminogen activator antigen is associated with endothelial dysfunction independent of other cardiovascular risk factors in hypertension. Circulation 102(18): 2; 605
Libetta, C.; Meloni, F.; Centore, F.; Bulgheroni, A.; Napodano, P.; Dal Canton, A. 1999: Plasma levels and blood mononuclear cell release of IL-18 in patients on hemodialysis. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 290A
Dschietzig, T.; Richter, C.; Bartsch, C.; Laule, M.; Stangl, K. 2000: Plasma levels and myocardial expression of Relaxin-2 are increased in human heart failure. Circulation 102(18): 2; 594
Fawzy, F.; Zanaty, A.F.; Gobran, T. 2001: Plasma levels and platelet expression of P-selectin in type 2 diabetics with foot ulcers. Diabetologia 44(Suppl 1): A 3
Jones, C.M.; Dickinson, T.M.; Egorin, M.J. 2003: Plasma levels and response to Imatinib in polycythemia vera. Blood 102(11): 921a-922a
Nishimura, Y.; Ohta, Y.; Azuma, M.; Ochiai, K. 1999: Plasma levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid before and after the occurrence of stroke in genetic hypertensive rats. Japanese Journal of Pharmacology 79(Suppl 1): 128P
Sala, C.; Barelli, M.; Buonamici, V.; Morganti, A.; Ambrosi, B.; Zanchetti, A. 2000: Plasma levels of BNP in mineralocorticoid and glucocorticoid hypertension in humans. Journal of Hypertension 18(Suppl 4): S64
Matera, G.; Quirino, A.; Barreca, G.S.; Iannone, M.; Palma, E.; Rotiroti, D.; Liberto, M.C. 2002: Plasma levels of CINC, TNFalpha and IL-1beta in anesthetized rats after Bartonella quintana LPS induction. Journal of Interferon and Cytokine Research 22(Suppl 1): S-87
Shokuhi, S.; Brady, M.; Bhatia, M.; Christmas, S.; Neoptolemos, J.P.; Slavin, J. 2000: Plasma levels of CXC chemokines ENA-78 and GRO-varies are elevated in severe pancreatitis. Gastroenterology 118(4 Suppl 2 Pt 1): A159
Bimenya, G.S.; Harabulema, M.; Okot, J.P.; Francis, O.; Lugemwa, M.; Okwi, A.L. 2010: Plasma levels of DDT/DDE and liver function in malaria control personnel 6 months after indoor residual spraying with DDT in northern Uganda, 2008. South African Medical Journal 100(2): 118-121
Lueftner, D.; Henschke, P.; Mesterharm, J.; Schildhauer, S.; Geppert, R.; Wernecke, K.D.; Possinger, K. 2002: Plasma levels of HER-2/neu, tumor type M2 pyruvate kinase and its tyrosine phosphorylated metabolite in advanced breast cancer. Anticancer Research 22(1B): 479
Dayton, M.A.; Li, B.D.; Smith, M.T.; Berkel, H.J.; Yu, H. 2001: Plasma levels of IGF-I are correlated with IGF-I expression in breast cancer patients, but not in the control women. Proceedings of the American Association for Cancer Research 42: 153
Yu, H. (He); Li, B.D.L.; Smith, M.; Glass, J. 2001: Plasma levels of IGFs and HER-2/Neu in breast cancer. Proceedings of the American Association for Cancer Research 42: 153-154
Apostolou, T.; Kapsimali, V.; Koumoustiotis, V.; Pappa, E.A.; Galinas, A.; Nikolopoulou, N.; Papasteriades, C.; Billis, A. 1999: Plasma levels of IL-1 and TNFalpha in dialysis patients Relationship with bone histology and serum bone markers. Nephrology Dialysis Transplantation 14(9): A208
Lonnemann, G.; Novick, D.; Rubinstein, M.; Schwartzburd, B.; Swissa, D.; Belzer, I.; Dinarello, C.A. 2000: Plasma levels of IL-18 binding protein are elevated in chronic renal diseases. Kidney and Blood Pressure Research 23(3-5): 264-265
Layseca, E.; Perez, L.F.; Torres Montes, A.; De La Fuente, H.; Baranda, L.; Portales Perez, D.P.; Gonzalez Amaro, R. 1999: Plasma levels of IL-6 and TNF-alpha and expression of CD64 as markers for neonatal sepsis. Abstracts of the General Meeting of the American Society for Microbiology 99: 661
Casasnovas, R.O.; Brice, P.; Divine, M.; Morschhauser, F.; Gabarre, J.; Blay, J.Y.; Voillat, L.; Lederlin, P.; Stamatoulas, A.; Bienvenu, J.; Guiguet, M.; Intrator, L.; Grandjean, M.; Ferme, C.; Salles, G.A. 2003: Plasma levels of IL6, IL1 receptor antagonist an soluble CD30 allow to identify a poor failure free survival subset of Hodgkins disease patients. Blood 102(11): 102a
Indelicato, M.; Falsaperla, M.; Porto, A.; La Rosa, I.; Malaponte, G.; Morgia, G.; Mazzarino, M.C. 2000: Plasma levels of MMP-2, MMP-9, MMP-13, TIMP-1 and activity of MMP-2 and MMP-9 in patients with prostate cancer. Acta Haematologica (Basel) 103(Suppl 1): 33
Guido, M.; Fagiuoli, S.; Tessari, G.; De Paoli, M.; Burra, P.; Leo, G.; Ferrari, C.; Rugge, M. 2001: Plasma levels of MMP-2, TIMP-1, and PIIIP as markers of liver disease in hepatitis C recurrent after liver transplantation. Journal of Hepatology 34(Suppl 1): 169
Groenning, B.A.; Raymond, I.; Pedersen, F.; Trawinski, J.; Baumann, M.; Dimsits, J.; Hildebrandt, P.R. 2001: Plasma levels of N-terminal pro brain natriuretic peptide are dependent of age and gender in a large sample of the general population. European Heart Journal 22(Abstract Suppl): 396
Shin, D.I.; Jaeckel, K.; Horlitz, M.; Schley, P.; Klein, M.; Fueth, R.; Bufe, A.; Lapp, H.; Scheffold, T.; Guelker, H. 2003: Plasma levels of N-terminal-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Circulation 108(17): IV322
Azuma, M.; Ohta, Y.; Nishimura, Y.; Ochiai, K. 1999: Plasma levels of NO metabolites in spontaneously hypertensive rats , stroke-prone SHR , and malignant and precocious SHRSP. Japanese Journal of Pharmacology 79(Suppl 1): 129P
James, S.J.; Yi, P.; Melnyk, S.; Hine, R.J.; Pogribny, I.P. 2000: Plasma levels of S-adenosylhomocysteine increase linearly with homocysteine levels and lymphocyte DNA hypomethylation. FASEB Journal 14(4): A202
Gazitt, Y.; Liu, Q. 2001: Plasma levels of SDF-1 and expression of SDF-1 receptor on CD34+ cells in mobilized peripheral blood of non-Hodgkin's lymphoma patients. Stem Cells 19(1): 37-45
Bertolaccini, M.L.; Atsumi, T.; Katsumata, K.; Khamashta, M.A.; Koike, T.; Hughes, G.R.V. 2000: Plasma levels of TNF alpha are increased in patients with the antiphospholipid syndrome. Journal of Autoimmunity 15(2): A90
Bertolaccini, M.L.; Atsumi, T.; Katsumata, K.; Khamashta, M.A.; Koike, T.; Hughes, G.R.V. 1999: Plasma levels of TNF alpha are markedly increased in patients with the antiphospholipid syndrome. Arthritis and Rheumatism 42(9 Suppl): S364
Ravera, A.; Golino, P.; Piscione, F.; D'andrea, D.; Cirillo, P.; Ragni, M.; Ezban, M.; Chiariello, M. 1999: Plasma levels of Tissue Factor Pathway Inhibitor are decreased in the coronary sinus of patients with acute myocardial infarction. European Heart Journal 20(ABSTR Suppl ): 194
Holten Andersen, M.N.; Nielsen, H.J.; Sorensen, S.; Jensen, V.; Brunner, N.; Christensen, I.B. 2002: Plasma levels of Tissue Inhibitor of Metalloproteinases 1 measured during follow-up of colorectal cancer patients have clinical value in predicting patient outcome. Proceedings of the American Association for Cancer Research 43: 715
Prusa, R.; Zadina, J.; Pechova, M.; Bonsch, M. 2002: Plasma levels of activated factor XII in patients with hyperglycaemia. Clinical Chemistry 48(6 Suppl): A158
Cappa, M.; Letizia, C.; Di Biase, A.; Subioli, S.; D'eramo, E. 1999: Plasma levels of adrenomedullin in patients with X-linked adrenoleukodystrophy. Hormone Research 51(Suppl 2): 79
Letizia, C.; De Toma, G.; Raejntroph, N.; Cerci, S.; Subioli, S.; Caliumi, C.; Scuro, L.; Verrelli, C.; Ferrari, P.; Celi, M.; D'erasmo, E. 2000: Plasma levels of adrenomedullin, new vasoactive peptide, in subjects with pheochromocytoma. Journal of Endocrinological Investigation 23(6 Suppl): 51
Olsen, A.; Landberg, R.; Aman, P.; Kamal-Eldin, A.; Christensen, J.; Johnsen, N.F.øn.; Overvad, K.; Tjønneland, A. 2010: Plasma levels of alkylresorcinols and incidence of endometrial cancer. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 19(1): 73-77
Tokuda, T.; Tamaoka, A.; Matsuno, S.; Sakurai, S.; Shimada, H.; Morita, H.; Ikeda, S. 2001: Plasma levels of amyloid beta proteins did not differ between subjects taking statins and those not taking statins. Annals of Neurology 49(4): 546-547
Zhao, H.; Zhang, H.; Chamberlain, R.M.; Grossman, H.B.; Wu, X. 2002: Plasma levels of angiogenin as a susceptibility marker for bladder cancer. Proceedings of the American Association for Cancer Research 43: 937-938
Duggan, A.; Ste Marie, R., J.; Callard, I.P. 1999: Plasma levels of apolipoprotein A and tissue expression of its receptor, SR-BI, in the freshwater turtle, Chrysemys picta. Biology of Reproduction 60(Suppl 1): 99
Karamsetty, M.R.; Bartlett, M.G.; Warburton, R.R.; Klinger, J.R.; Hill, N.S. 2002: Plasma levels of arginine and methylated arginines in rats with pulmonary hypertension. FASEB Journal 16(5): A954
Jonasson, T.F.; Hedner, T.; Hultberg, B.; Ohlin, H. 2001: Plasma levels of asymmetric dimethylarginine are not increased in patients with coronary artery disease and hyperhomocysteinemia. Journal of the American College of Cardiology 37(2 Suppl A): 303A
Del Ry, S.; Clerico, A.; Caprioli, R.; Andreassi, M.G.; Gazzetti, P.; Giannessi, D. 1999: Plasma levels of atrial and brain natriuretic peptide in patients with renal insufficiency. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S177
Odar Cederlof, I.; Bjellerup, P.; Willians, A.; Blagg, C.R.; Kjellstrand, C.M. 2000: Plasma levels of brain natriuretic peptide decrease in daily dialysis. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 292A
Oguz, A.; Pinarli, F.G.; Karadeniz, C.; Tunaoglu, S.; Gokcora, N.; Elbeg, S. 2003: Plasma levels of brain natriuretic peptide in children with solid tumors treated by anthracycline chemotherapy. EJC Suppls 1(5): S194
Sarasso, G.; Airoldi, L.; Frongia, E.; Bertona, R.; Occhetta, E.; Vassanelli, C. 2000: Plasma levels of brain natriuretic peptide in hypertensive patients are related to left ventricular remodelling patterns. European Heart Journal 21(Abstract Suppl): 619
Shevchenko, O.P.; Shumakov, D.V.; Ckiladze, E.S.; Chilikina, G.V.; Shevchenko, A.O.; Chervyakova, N.V. 2001: Plasma levels of ceruloplasmin , haptoglobin and C-reactive protein in patients after cardiopulmonary bypass. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S348
Sánchez, C.; López-Jurado, M.ía.; Aranda, P.; Llopis, J. 2010: Plasma levels of copper, manganese and selenium in an adult population in southern Spain: influence of age, obesity and lifestyle factors. Science of the Total Environment 408(5): 1014-1020
Schuld, A.; Kraus, T.; Haack, M.; Hinze-Selch, D.; Kühn, M.; Pollmächer, T. 2000: Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schizophrenia Research 43(2-3): 164-166
Rajvanshi, P.; Farrand, A.L.; Bouvier, M.E.; Batchelder, A.; Mcdonald, G.B. 2000: Plasma levels of endothelin-1 and nitrate in patients with venocclusive disease of the liver after hematopoietic cell transplantation. Hepatology 32(4 Pt 2): 405A
E.K.rchi, G.; Prats, C.; Giralt, M.; Perez, B. 2003: Plasma levels of enrofloxacin and ciprofloxacin in different species after therapeutic administration. Journal of Veterinary Pharmacology and Therapeutics 26(Suppl 1): 124-125
Raeside, J.I.; Christie, H.L.; Renaud, R.L. 2000: Plasma levels of estrogen-fatty acid esters in the male pig. Journal of Reproduction and Fertility Abstract Series 25: 78
Lapp, H.; Krakau, I.; Horter, C.; Hartmann, C.; Homann, B.; Gehrmann, M.; Unger, S.; Voelker, M.; Burchardt, E.R. 2000: Plasma levels of extracellular matrix proteins as a marker of myocardial remodelling A quantitative analysis. European Heart Journal 21(Abstract Suppl): 24